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Abstract 
GABAA receptors form the major class of inhibitory neurotransmitter receptors in the 
mammalian brain. This review sets out to summarise the evidence that variations in genes 
encoding GABAA receptor isoforms are associated with aspects of addictive behaviour in 
humans, while animal models of addictive behaviour also implicate certain subtypes of 
GABAA receptor. In addition to outlining the evidence for the involvement of specific 
subtypes in addiction, we summarise the particular contributions of these isoforms in 
control over the functioning of brain circuits, especially the mesolimbic system, and make a 
first attempt to bring together evidence from several fields to understanding potential 
involvement of GABAA Receptor Subtypes in addictive behaviour. While the weight of the 
published literature is on alcohol dependency, the underlying principles outlined are 
relevant across a number of different aspects of addictive behaviour. 
Key Words: alcohol; psychostimulant; nucleus accumbens; gene association; gene knockout; 
animal model; reward;  impulsivity; benzodiazepine; conduct disorder; electrophysiology 
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1 Introduction 
 
Both human and animal studies have implicated GABAA receptors in addiction processes.  
This paper sets out to review the evidence for GABAA receptor involvement in relation to 
alcoholism and addiction to other drugs of abuse. It will begin with a summary of the 
structure and function of GABAA receptors and their subtype diversity, before reviewing the 
human and animal literature providing genetic and behavioural evidence for the role of 
GABAA receptors in addictive behaviour. Finally, we will attempt to integrate these data into 
our understanding of addiction processes, and their underlying neurobiology. While the 
review concerns itself broadly with GABAergic systems and addictive behaviour, the weight 
of the published literature is on alcohol dependency. Nevertheless, the underlying principles 
outlined are relevant across a number of different aspects of addictive behaviour. 
 
 
1.1 GABAA receptors 
 
GABAA receptors are members of the cys-loop family of ligand gated ion channels that 
additionally includes acetylcholine nicotinic, 5HT3, and strychnine-sensitive glycine 
receptors. GABAA receptors are heteromeric protein complexes, composed of five subunits 
arranged around a central axis to form an anion-selective ion channel, permeable to 
chloride and bicarbonate ions (Olsen and Sieghart, 2008, Macpherson et al., 2016). In the 
central nervous system (CNS), GABAA receptors are expressed in both neurons and glial 
cells. The binding of the neurotransmitter, GABA, to specific binding sites on the complex, 
transiently stabilizes the complex in an open conformation, allowing ionic flux. In most 
circumstances, the electrochemical gradient (combining the reversal potential for Cl- ions, 
ECl, and the cell’s resting membrane potential, Vm) allows for an influx of chloride ions 
resulting in a hyperpolarisation of the membrane that, in turn, makes the neuron less 
susceptible to depolarization by other neurotransmitters such as glutamate. Moreover, by 
decreasing the cell input resistance, GABA acts as a “shunt” for incoming signals. Thus, in 
most circumstances, GABA acts as an inhibitory neurotransmitter, dampening down the 
excitability of its target neurons.  
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In addition to expressing binding sites for GABA, the natural neurotransmitter, GABAA 
receptors also possess a variety of allosteric sites at which a number of other agents act (Fig 
1),  including the benzodiazepines, certain naturally occurring neurosteroids and a number 
of structurally diverse i.v. general anaesthetics e.g. propofol, etomidate, barbiturates (Belelli 
and Lambert, 2005). These compounds act as positive allosteric modulators (PAMs) to 
enhance the function of GABA by stabilising the open conformation of the channel in the 
presence of the agonist. Additionally, at greater concentrations than those required for this 
GABA-enhancing action, the neurosteroids and i.v. anaesthetics can directly gate the 
receptor-channel complex in the absence of GABA, a so called “GABA-mimetic” effect. Note 
that benzodiazepines do not share this “agonist” property.  As regards GABAA receptor 
inhibitors, picrotoxin acts as a GABAA receptor antagonist, by binding to amino acid residues 
forming the lining of the chloride ion channel pore. Bicuculline and gabazine bind to, or 
close to, the binding site for GABA, with the former acting as a negative allosteric modulator 
(NAM) and the latter as a true competitive antagonist. Additionally, there are binding sites 
for Zn2+, which may act as an endogenous modulator of GABAAR function, and possibly for 
alcohol.  
 
1.2 Subtypes of GABAA receptor 
 
GABAA receptors are typically composed of 5 protein subunits arranged around a central 
pore that forms the ion channel (Fig 1). Each subunit consists of a large N-terminal 
extracellular domain (at which both the natural ligand, GABA, and pharmaceuticals such as 
benzodiazepines interact with the complex), four hydrophobic transmembrane domains 
(TM1-4), of which TM2 is thought to line the pore of the channel, and a large intracellular 
loop between TM3 and TM4 which may contribute to the ion pore pathway and also may 
incorporate kinase consensus sequences that influence receptor function and trafficking 
(Kittler and Moss, 2003). The GABA binding site is located between the α and β subunit 
interface and that for benzodiazepines in an equivalent location between the α and γ 
subunit interface. In mammals, nineteen different subunit proteins have been identified, 
and classified into eight families, based on sequence homology. Several of the families have 
multiple members: α (1–6), β (1–3), γ (1–3), δ, ε, ρ (1–3), θ and π, and within a family, 
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subunits have a high sequence similarity (Olsen and Sieghart, 2008). Further, for some 
GABAA subunit isoforms (e.g. γ2, α4 & α6), alternative splicing allows a further complexity in 
the protein product (Bateson et al., 1991, Petrie et al., 2001).  
 
This diversity of subunits fosters the possibility for a very large number of permutations to 
give a pentameric structure (over a million), but in reality, only a limited number (about 30-
40) of GABAA receptor subtypes have been estimated to be naturally expressed (Olsen and 
Sieghart, 2009, Fritschy and Panzanelli, 2014); (see also Section 1.3, GABAA receptor subunit 
chromosomal localisation, for co-ordinated expression of subunits).  
 
Most mammalian receptors appear to consist of 2 members of the α family, 2β, and one γ 
subunit (Fig 1). Alternatively, in less abundant subtypes, the γ subunit is replaced by a δ or 
an ε subunit. While for any individual receptor, both α subunits are likely to be of the same 
isoform, hybrid receptors with two different forms of α subunit also occur (Nusser et al., 
1998). Furthermore, although the natural ligand for all combinations known to exist is 
GABA, some allosteric modulators interact with only a subset of these possible receptor 
complexes. Thus, for classical benzodiazepines (e.g. diazepam) to interact with the receptor 
complex, it must contain particular members of the α family (α1, α2, α3, α5) along with 
members of the β family, and a γ2 subunit. However, certain atypical benzodiazepines 
and β-carbolines act at these benzodiazepine-sensitive complexes to negatively modulate 
the channel in an allosteric fashion and are thus termed  “inverse agonists” or negative 
allosteric modulators (NAMS) (i.e., they reduce the effects of GABA). These substances also 
bind to α4 and α6/β/γ2 complexes where they function as positive allosteric modulators 
(PAMs) (Walker and Semyanov, 2008).  A distinct group of receptors that has received 
recently significant interest is made up of α4 or α6 subunits together with β and δ subunits.  
 
Fig 1 near here 
 
Different combinations of subunits have differing physiological (e.g. single channel 
conductance, ion channel kinetics) and pharmacological properties and are heterogeneously 
distributed within the brain, and within neuronal cellular domains. Thus, receptors 
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containing α1, 2, 3 or 5 subunits, together with β1/2/3 and γ2 subunits largely interact with 
scaffold proteins (such as gephyrin), to cluster at the postsynaptic membrane (Farrant and 
Nusser, 2005, Fritschy et al., 2012). However, the same isoforms can also localise to 
extrasynaptic cellular domains (e.g. α5βγ2 receptor subtype (Fritschy and Panzanelli, 2014)). 
Alternatively, receptors made up of α4  or α6, in combination with β and δ subunits exhibit 
an exclusively extrasynaptic localization and may respond to overflow of GABA from the 
synapse (Belelli et al., 2009, Herd et al., 2013, Walker and Semyanov, 2008). The brain 
region-selective distribution of the various subunits suggested early on that GABAA receptor 
heterogeneity likely subserves differential functional and physiological roles, so that the 
pharmacological targeting of a particular subunit combination may associate with more 
subtle behavioural effects than those typically displayed by drugs with a broad spectrum of 
actions (e.g. classical  benzodiazepines and barbiturates), which facilitate transmission at a 
wide variety of GABAA receptors located within different neuronal networks (McKernan and 
Whiting, 1996, Whiting, 2003).  
 
This proposal found substantial support from a series of elegant experiments in mice in 
which individual members of the α family were mutated to render them insensitive to 
classical benzodiazepines (e.g. diazepam). Despite their high sequence homology with other 
members of the α subunit family, the benzodiazepine-insensitive α4 and α6 subunits differ 
from the other family members by virtue of a crucial arginine (R) residue, which replaces 
histidine (H) in the homologous position of the benzodiazepine binding domain. Taking 
advantage of this observation, the groups led by Möhler and McKernan developed a 
number of mouse lines engineered to harbour a mutated α subunit gene i.e. α1(H101R), 
α2(H101R), α3(H126R) or α5(H105R) to impart benzodiazepine insensitivity to the receptors 
incorporating the mutated subunits (Rudolph et al., 1999, McKernan et al., 2000). 
Behavioural analysis of these mouse lines has allowed the dissection of the pharmacological 
repertoire normally associated with the administration of classical benzodiazepines. Thus, 
the sedative properties and anxiolytic properties of benzodiazepines have been shown to be 
mediated by α1-containing  and α2- (and perhaps α3-) subunit containing receptors 
respectively, while an action at α5-containing receptors makes a significant contribution to 
the well-characterised amnestic effects of benzodiazepines (Mohler et al., 2002, Collinson et 
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al., 2006, Rudolph and Knoflach, 2011). Taking advantage of the β-subunit selectivity of 
etomidate, a similar approach has been also successfully applied to dissect the contribution 
of distinct β subunit-containing isoforms (β1-3) to the constellation of behavioural effects 
associated with general anaesthetic usage (e.g. sedation, immobility, hypnosis) (Reynolds et 
al., 2003b, Kretschmannova et al., 2013). Although acquired in the context of discovering 
potential selective targets for benzodiazepine-like ligands and general anaesthetics, these 
data point to quite separate roles for subtypes of GABAA receptor in different brain circuits, 
and hence behavioural function.  
 
1.3 GABAA Receptor Subunit Chromosomal Localisation 
In humans, genes encoding 14 of the 19 GABAA receptor subunits are found in four major 
clusters located on chromosomes 4, 5, 15 and X (Fig 2 (Buckle et al., 1989, Dean et al., 1991, 
McLean et al., 1995, Bell et al., 1989, Greger et al., 1995, Hicks et al., 1994, Johnson et al., 
1992, Russek and Farb, 1994, Sommer et al., 1990, Wilcox et al., 1992). The chromosome 4 
cluster (chr 4) contains genes encoding γ1, α2, α4 and β1 subunits, the chromosome 5 
cluster (chr 5) contains genes for α1, α6, β2 and γ2 subunits, the chromosome 15 cluster 
α5, β3, γ3 subunits and the X chromosome α3, ε, and θ subunits. Syntenic regions for the 
human clusters occur in the mouse (Fig 2) suggesting a highly conserved organisation of 
these genes. Thus, the chr 4 cluster of GABAA receptor genes is also found on mouse 
chromosome 8 (chr 8; www.ensembl.org), and the human chr 5 cluster on mouse 
chromosome 11 (chr11) (Garrett et al., 1997). The highly conserved organisation of the 
genes in clusters raises the question as to whether the expression of genes within each 
chromosomal cluster may be co-regulated (cis effects) and, additionally, whether there is 
correlation of gene expression between GABAergic genes that are located in different 
chromosomes (trans effects). Interestingly, expression of those genes located on human chr 
4 (and mouse chr 8) predominate in rodent embryo, but these genes are generally down 
regulated in the adult rat (Wisden et al., 1992, Laurie et al., 1992), and presumably other 
mammals, except in particular structures including the cortical areas, thalamus, 
hippocampus, amygdala, the majority of dopamine (DA) neurons in the substantia nigra and 
the VTA, where they continue (especially the α4 and α2 genes) to be highly expressed 
(Laurie et al., 1992, Pirker et al., 2000, Schwarzer et al., 2001). 
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It is noteworthy that three of the chr 5 cluster genes encode the most frequently expressed 
GABAA α1β2γ2 receptor, while the chr 4 genes encode the GABAA receptor subunit group 
α2β1γ1 that is found almost exclusively in the addiction-related mesolimbic pathways 
encompassing ventral tegmental area (VTA) and ventral striatal regions, consistent with 
coordinated transcription within clusters (Enoch et al., 2013). A recent factor analysis by 
Enoch and colleagues (Enoch et al., 2013) suggested that the GABAA gene clusters show 
both cis and trans correlations of gene expression. In particular, expression levels of the chr 
5 genes were correlated highly, not only with other genes within that cluster, but two chr 15 
genes, GABRB3 (encoding subunit β3) and GABRG3 (γ3) also had high loadings (0.8) on this 
factor, while the chr 4 gene GABRA4 (α4) and the chr X gene GABRA3 (α3) loaded more 
modestly (0.7–0.6). A second group of genes, namely the four GABAA subunit genes in the 
chr 4 cluster, loaded onto a factor that accounted for 0.14 of the total variance in GABAergic 
gene expression: GABRG1 (1.0); GABRA2 (0.8); GABRB1 (0.8) and GABRA4 (0.5), though the 
authors note that GABRA4 expression correlated better with expression of the chr 5 genes 
(Enoch et al., 2013). Such correlations of expression levels might suggest that a common 
mechanism underlies coordinated expression of some subunits, favouring formation of 
particular receptor assemblies. 
 
1 Evidence for GABAA receptor involvement in addiction 
In the remainder of this review we shall discuss evidence from both human and animal 
studies implicating an important role for GABAA receptors in drug addiction. Alcohol 
because of its widespread abuse and availability of considerable documented research, will 
be the main focus of this narrative with additional references to other substances of abuse 
e.g. cocaine and amphetamine-like psychostimulants where appropriately documented.  
   
2.1 Human gene association studies 
 
2.1.1 Chromosome 4 cluster: (γ1, α2, α4 and β1) 
 
2.1.1.1 GABRA 2 
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A number of studies over the past twenty years has suggested a linkage between alcohol 
dependence and chromosome 4p at the location of the GABAA gene cluster (Ghosh et al., 
2003, Long et al., 1998, Porjesz et al., 2002, Reich et al., 1998, Zinn-Justin and Abel, 1999). 
More recent studies (using the Collaborative Study on the Genetics of Alcoholism (COGA) 
cohort) have identified two haplotype blocks extending downstream from intron 3 within 
GABRA2, with the more common haplotype being a significant risk factor for alcohol 
dependence (Edenberg et al., 2004). This finding was confirmed in a German population 
(Soyka et al., 2008). However, subsequent analysis of the COGA dataset revealed that this 
association held only for those alcoholics who additionally had dependence on other, illicit, 
drugs (Agrawal et al., 2006), while a further study discovered that the GABRA2 variants were 
associated with symptoms of childhood conduct disorder in children, though not with 
alcohol dependence in this population (Dick et al., 2006b). More recently, an association of 
only a particular SNP (rs9291283) with both alcohol abuse and conduct disorder was found 
(Melroy et al., 2014). Such evidence might suggest that genetically-associated conduct 
disorder gives rise to drug, or alcohol misuse as part of the disorder. 
 
While several studies have confirmed a link between GABRA2 variants and alcoholism, other 
studies have found that the less frequent haplotype is associated with alcohol dependence 
in Americans of Caucasian origin (Covault et al., 2004), Russians (Lappalainen et al., 2005), 
and Germans (Fehr et al., 2006). In contrast to the Agrawal report that limits the association 
to alcoholics with comorbid illicit drug dependence, others (Covault et al., 2004) found the 
relationship to be most prominent in individuals without comorbid illicit drug dependence. 
These apparent paradoxes may reflect different populations of alcoholics, those with the 
more frequent haplotype being associated with alcoholism characterised by high trait 
anxiety, while low-anxiety alcoholics may be more likely to possess the low-frequency 
haplotype (Enoch, 2008) (See also discussion below on Type I and Type II alcoholism); 
however, possession of trait anxiety by itself was not associated with GABRA2 variations 
(Enoch et al., 2006). In keeping with that interpretation, the COGA alcoholic population 
which suggested an association of the more frequent haplotype with alcoholism (Edenberg 
et al., 2004), was shown to possess a high trait anxiety compared to the non-alcoholic group 
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(Ducci et al., 2007). Importantly, a post mortem study of brains of alcoholics found lower α2 
subunit mRNA in the central amygdala nucleus of alcoholic patients (Cammarota et al., 
1995), though, in this case it cannot be determined whether the lowered expression level 
resulted from long term alcohol abuse rather than being a predisposing influence. 
 
Although a number of studies have failed to find an association between GABRA2 and 
alcoholism (Covault et al., 2008, Drgon et al., 2006, Matthews et al., 2007), given the 
heterogeneity of types of alcoholism, this may not be surprising. The association may be 
strongest in males, while females do not show such an association (Enoch, 2008). From this 
point of view, the classification of alcohol use disorders is of interest. Type I alcoholism is 
characterised by late onset and neurotic predisposition, and distinguished from Type II 
alcoholism with a relatively early onset, and presence of delinquent behaviour (Cloninger et 
al., 1988). Whereas Type I is not strongly heritable and found more often in females, Type II, 
almost exclusively seen in males, is strongly heritable. In keeping, a recent study (Strac et 
al., 2015), which examined associations between three GABRA2 SNPs (rs567926, rs279858 
and rs9291283) and alcohol dependence, not only showed an association between 
rs279858 and alcohol dependence, but the A–C (rs567926 and rs279858) haplotype was 
more frequently seen in Cloninger Type II alcoholics (presenting with a combination of early 
onset alcohol abuse and aggression). 
 
A recent meta-analysis found strong associations between GABRA2 and alcohol dependence 
for SNP rs567926 and rs279858), and between GABRG2 and dependence both on alcohol 
and heroin for rs211014. A significant association was also observed between GABRA6 
rs3219151 and Alcohol Use Disorder (Li et al., 2014). Nevertheless, and perhaps surprisingly, 
GWAS studies have failed to support the widely replicated GABRA2 finding. In a GWAS of 
nearly 2,000 alcoholics and 2,000 controls, five GABRA2 SNPs had only a nominal 
association (p<0.05) with Alcohol Use Disorder, with odds ratios of 1.1 – 1.7 (Bierut et al., 
2010), perhaps indicating that the direct contribution of GABRA2 genotypic variants to 
alcoholism genetics may be minor. However, given the heterogeneity of “Alcohol Use 
Disorder” as a phenotype, and the evidence that alcohol abuse is only one of a number of 
disorders of behavioural control associated with GABRA2 variants, perhaps it is unsurprising 
that GWAS finds only weak associations of GABRA2 with alcohol abuse.  
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2.1.1.2 Other chromosome 4 cluster GABAA receptor subunit association with alcohol 
abuse 
 
There is only limited evidence from gene association studies that other GABAA receptor 
subunit genes located on chr 4p may be involved in addiction risk. The original (Edenberg et 
al., 2004) study reported a trend for association for two GABRG1 SNPs, while a haplotype 
block that extends from the intergenic block between GABRA2 and GABRG1 up to GABRG1 
intron 3 was identified in two groups of Americans of Caucasian origin, but not those of 
African descent (Covault et al., 2008). Note that the polygenic markers in the GABRG1 gene 
are in linkage disequilibrium with markers on the GABRA2 gene, and have been found to 
contribute to risk of alcohol dependence in an additive manner, with the polymorphic 
markers in the GABRA2 gene providing the dominant effect (Covault et al., 2008). 
Nevertheless, other researchers reported that the GABRA2 and GABRG1 genes likely 
provide independent contributions to alcohol vulnerability (Enoch et al., 2009).  
Some studies have reported a robust association between GABRB1 and alcohol dependence 
comorbid with other substance dependence and psychiatric illnesses (Yang et al., 2012, 
Kertes et al., 2011), although the strength of the association with alcohol dependence alone 
is less clear (Parsian and Zhang, 1999, Dick and Foroud, 2003, Song et al., 2003, Reck et al., 
2005). Very recently, an association has been identified between the intergenic SNP 
rs2044081 in GABRB1 and alcohol dependence in a well characterized British/Irish 
population (Odds Ratio 4.2 [95% Confidence Intervals 1.5-11.5] Pcorrected 3.31x102) 
(M.Y.Morgan et al (personal communication). Exploiting the IMAGEN database (Schumann 
et al., 2010), we explored in an adolescent population whether possession of the minor (T) 
variant of this SNP is associated with performance of tasks measuring aspects of impulsivity, 
and reward sensitivity that are implicated in drug and alcohol abuse. Allelic variation did not 
associate with altered performance in either a stop-signal task (SST), measuring one aspect 
of impulsivity, or a monetary incentive delay (MID) task assessing reward anticipation. 
However, increased BOLD response in the right hemisphere inferior frontal gyrus, left 
hemisphere caudate/insula, and left hemisphere inferior temporal gyrus during MID 
performance was higher in the minor (T) allele group. In contrast, during SST performance, 
the BOLD response found in the right hemisphere supramarginal gyrus, right hemisphere 
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lingual and left hemisphere inferior parietal gyrus indicated reduced responses in the minor 
genotype.    We suggest that β1-containing GABAA receptors may play a role in excitability of 
brain regions important in controlling reward-related behaviour, which may contribute to 
susceptibility to addictive behaviour (Duka et al., in press).        
 
2.1.2 Chromosome 5 cluster (α1, α6, β2 and γ2) 
 
There is considerably less evidence that genes within the chr 5 cluster are associated with 
addictions. Initial analysis of the COGA database revealed no linkage between chromosome 
5 genes and alcoholism (Dick et al., 2005, Song et al., 2003), though a subsequent analysis 
found an association of GABRA1 with individual indications of risk for alcohol dependence; 
these included a history of blackouts, age at first drunkenness, and level of response to 
alcohol (Dick et al., 2006c). Other members of the cluster, GABRA6 and GABRB2, have been 
associated with alcohol dependence in both a Finnish, and a Native American population 
(Radel et al., 2005), and with both alcohol dependence and Korsakoff's psychosis in a 
Scottish study (Loh et al., 2000b), while (Loh et al., 2000a) reported an association of 
antisocial alcoholism with GABRG2 in a Japanese population.  On the other hand, another 
study (Sander et al., 1999) found no association of GABRB2, or GABRG2 with alcohol 
dependence in a German population.  
 
A low level of sedation following alcohol is thought to represent a risk factor for developing 
alcohol dependence, and a non-significant trend for an association between possession of 
the GABRA6 Ser385 allele and a low sedative response to alcohol has been reported (Hu et 
al., 2005). The Ser385 allele is uncommon, and the study contained no homozygous cases, 
and only 18 individuals who were heterozygous for the Ser385 allele. Nevertheless, the six 
men with heterozygous (Pro385/Ser385) genotypes had the lowest sedative response to 
alcohol, and each had developed alcoholism during follow-up. However, in a previous study, 
the same allele was associated with lower levels of neuroticism and conspicuously, reduced 
anxiety, hostility and depression scores, but not with alcohol use (Sen et al., 2004).  
Curiously, the same substitution is associated with reduced sensitivity to diazepam in 
children of alcoholics (Iwata et al., 1999), though classic benzodiazepines do not bind to 
GABAA receptors incorporating the α6 subunit. Perhaps the substitution induces a sub-
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threshold increase in arousal, a phenotype that could reduce independent influences on 
sedation.  
 
2.1.3 Chromosome 15 cluster (α5, β3, γ3) 
 
Studies using the COGA dataset have found evidence of haplotype and SNP association 
between alcohol dependence and GABRG3 (Dick et al., 2004). Interestingly, paternal, but 
not maternal, transmission of GABRA5 and GABRB3 alleles showed association with 
alcoholism (Song et al., 2003), consistent with this chromosomal location being subjected to 
genetic imprinting (Meguro et al., 1997). 
 
The atypical benzodiazepine derivative, Ro15-4513, has been reported to have a relatively 
higher affinity for the α5 subunit-containing GABAA receptors (α5-GABAARs) over those 
incorporating α1, α2, α3 subunits, both for in vitro  and in vivo studies (Luddens et al., 1994, 
Wieland and Luddens, 1994, Momosaki et al., 2010), and this observation has been used to 
exploit [11C]Ro15-4513 binding in PET studies of human brain as a measure of  the density of 
α5-GABAARs. Using this method, the expression of α5-GABAARs is reduced in the brains of 
alcoholic patients, particularly in limbic regions, including the nucleus accumbens (NAcc) 
(Lingford-Hughes et al., 2012). Note that Ro 15-4513 had been suggested previously to 
target high affinity α4βδ receptors (Hanchar et al., 2006), which have been implicated in 
alcohol reward (Rewal et al., 2009, Rewal et al., 2012). However, the demonstration that 
approximately 90% of high affinity Ro 15-4513 binding is lost in the brains of mice rendered 
insensitive to this atypical BZ ligand by a point mutation in the γ2 subunit (F77I), and, 
moreover, that Ro 15-4513 binding is prominent in regions devoid of δ subunit expression 
(Linden et al., 2011) question the relevance of δ-GABAA receptors as a pharmacological 
target for Ro 15-4513 actions.   
 
2.1.4 X chromosome (α3, ε, and θ). 
 
We are unaware of any studies indicating associations of these genes with alcohol-related 
disorders in human populations. 
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2.1.5 GABAA receptor associations with other addictions 
 
While by far the majority of studies on gene-addiction associations have concentrated on 
alcohol dependence, a limited number have investigated the association of GABAA receptor 
subunit genes and addiction to other abused drugs. Human genetic studies suggest GABAA 
receptors containing the α2 subunit may play a role in nicotine dependence (Agrawal et al., 
2008b) and cannabis abuse (Agrawal et al., 2008a). We found an association of GABRA2 
variants with cocaine addiction in a Brazilian population of Caucasian ancestry (Dixon et al., 
2010). While our study characterised a different set of SNPs from those reported most 
frequently for the alcohol studies, one risk SNP from our study, rs279871, is in 100% linkage 
disequilibrium with rs279858 widely reported by other groups, suggesting we are studying 
the same haplotype. This and other intronic SNPs in the vicinity may tag a region that 
regulates mRNA transcription and stability and thus may alter expression of the GABRA2 
gene.  In a parallel study, African American male patients with lifetime DSM-IV single and 
comorbid diagnoses of alcohol, cocaine, and heroin dependence were characterised (Enoch 
et al., 2010).  One haplotype predicted heroin addiction, whereas a second haplotype was 
more common in control subjects and seemed to confer resilience to addiction after 
exposure to severe childhood trauma. A further SNP, rs11503014, not located in any 
haplotype block and potentially implicated in exon splicing, was independently associated 
with heroin addiction; childhood trauma interacted with rs11503014 variation to influence 
addiction vulnerability, particularly to cocaine. Thus, in some populations, and for some 
drugs, GABRA2 variants may contribute to the development of addictions by increasing 
vulnerability to early-life stress, a factor known to predispose to adult addictive behaviour 
(Enoch, 2011, Messina et al., 2008, Cadet, 2016).  
 
Subsequent studies have suggested associations of GABRB2 (Kim et al., 2015), GABRB3 
(Chen et al., 2014), and GABRG2 (Loh et al., 2007) SNPs with opiate dependence in Han 
Chinese people. Very recently, further evidence for an association of GABRB2 and GABRB3 
with opiate or cocaine dependence was reported (Levran et al., 2016), though this 
association did not survive stringent analysis. Reporter gene assays find the risk allele 
increases expression of GABRB3 and this may contribute to its pathogenesis (Chen et al., 
2014). Finally, a gender selective association of the novel SNPs rs2279020 and rs4480617 in 
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the GABRA1 and GABRG2 with methamphetamine abuse have been reported (Lin et al. 
2003). 
 
 
2.2 Animal studies implicating GABAA receptor subtypes in drug abuse 
 
The human gene association studies linking GABAA receptor subtypes to drug and alcohol 
abuse and dependence, are paralleled by functional studies in animals investigating these 
receptors in drug abuse. Drug (e.g. alcohol) consumption investigated both in animals 
selectively bred for high alcohol intake and genetically altered rodents, provides a direct 
measure that appears to model human consumption, but provides relatively little insight 
into the underlying mechanisms. However, because of the relative ease of performing such 
experiments they provide much of the data on the consequences of genetic manipulation 
for alcohol-related behaviour. More sophisticated measures include operant performance 
to obtain alcohol, as such studies can discriminate between motivational effects and 
consumption.  
 
In the accompanying sections both types of studies will be reviewed with an emphasis on 
alcohol but extended to other drugs with abuse and dependence liability as appropriate. 
 
2.2.1 Altered expression of GABAergic genes in animals selectively bred for high drug 
taking 
 
Several rat lines have been bred for high alcohol consumption. These lines provide certain 
parallels to human high consumption, and allow direct measurements to be made of 
receptor expression in discrete brain areas, both in drug-naïve animals, and following drug 
exposure. However, surprisingly few studies have sought to identify changes in GABAA 
receptor gene expression in various alcohol preferring lines. Studies from the Indiana  group  
(McBride et al., 2012, McBride et al., 2013b) are notable in showing a paucity of common 
gene differences among 5 pairs of rat lines independently bred for high alcohol 
consumption, and their non-preferring counterparts, in brain areas commonly implicated in 
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addictive behaviour, e.g., the accumbens shell, central amygdala and ventral tegmental 
area. None of these differences involved genes encoding GABAA receptor subunits. Such 
findings suggest that high alcohol consumption is under the control of many diverse genes, 
different combinations of which are selected during selective breeding for high alcohol 
consumption, and, from the point of view of the current review, such selective breeding 
does not depend importantly upon varying expression levels of GABAA receptor subunit 
genes (at least in the brain areas studied).   
 
Nevertheless, some studies using microarrays to investigate genome-wide differences in 
gene expression have reported altered GABAA gene expression. Thus, the level of mRNA 
encoding the β1 subunit of the GABAA receptor was 1.6-fold higher in iP (Indiana alcohol 
preferring) than iNP (non-preferring) rats and the level of expression of mRNA for the α1 
subunit was higher in the hippocampus of the iP than iNP rats (Homer et al., 2007). P rats 
also exhibited significantly higher levels of the α1 subunit protein relative to NP rats in the 
ventral pallidum (Halyburton et al., 2007). These differences in expression may not be 
primary; the iP rat has a lower GAD expression in the hippocampus, suggesting reduced 
GABA function, so that the iP rat may produce a compensatory upregulation of the 
GABAA receptor. 
 
Gabrg2, encoding the γ2 subunit, together with Gphn encoding the associated scaffolding 
protein, gephryin, required for postsynaptic clustering of GABAA receptors, are both up-
regulated in P rats (in contrast to the their down regulation in human alcoholics and cocaine 
addicts). P rats also show a significant up-regulation in expression of Gabrg2 and 
Gabrg3 gene expression, together with a trend towards a down-regulation 
of Gabrb3 (Enoch et al., 2012). In an independent line of Warsaw alcohol-preferring and 
non-preferring rats, without exposure to alcohol, a down-regulation of Gabra4 was found in 
hippocampus (Stankiewicz et al., 2015). 
 
2.2.2 Gene association studies:  Drug self-administration 
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The availability of an extensive number of mouse recombinant inbred strains derived by 
inbreeding novel inbred strains from the F2 cross between C57BL/6J (B6) and DBA2/J (D2) 
mice (so-called BXD strains) has been frequently exploited to identify quantitative trait loci 
(QTLs) of genes associated with complex behavioural traits including responsiveness to 
several aspects of alcohol- and other drug-related behaviours (Crabbe et al., 1999, Phillips et 
al., 2002). The availability of related approaches in humans offers the hope of integrating 
mouse and human studies (Ehlers et al., 2010). While, for practical reasons, such analyses 
are usually based on simple measures of alcohol consumption, or easily-scored 
consequences of alcohol administration, or withdrawal, several QTLs associated with 
alcohol dependence have been identified in chromosomal regions that contain genes that 
encode GABAA receptor subunits (see (Boehm et al., 2004) for a review). Thus, a QTL for 
alcohol withdrawal spans a region on mouse chromosome 11 that contain the genes 
encoding α1, α6, β2 and γ2 subunits (Buck et al., 1997, Bergeson et al., 2003), but nearby, 
or overlapping loci are also associated with alcohol tolerance, alcohol-conditioned taste 
aversion, alcohol-induced hypothermia, and alcohol-induced motor incoordination (Crabbe 
et al., 1994, Risinger and Cunningham, 1998, Browman and Crabbe, 2000, Kirstein et al., 
2002, Phillips et al., 1996). Using the WebQTL (www.webqtl.org) facility (Wang et al., 2003, 
Chesler et al., 2003), Boehm et al. (2004) related these behavioural observations to levels of 
gene expression of the respective GABAA receptor subunits in either cerebellum or 
forebrain; significant correlations were found for individual subunits, but these differed to 
an extent depending on the behaviour, and brain area studied. Similarly, associations with 
alcohol-related phenotypes were found for mouse chromosome 5 QTLs containing the 
genes encoding α2, α6, β2 and γ1 subunits, and in these cases significant correlations were 
found only for forebrain expression levels of the α2 subunit: for chromosome 7 (α5, β3 and 
γ3) with significant correlation with expression of β3, and chromosome 4 (δ and ρ1 and ρ2). 
Nevertheless, it is not clear whether these associations inform on a functional involvement 
of these subunits in the effects of alcohol, or whether they reflect the involvement of these 
genes in the level of performance of the respective tasks used to assess alcohol’s effects, 
allowing alcohol (or any other agent) to exert its effects more readily when performance is 
already partly compromised by altered level of gene expression. On the other hand, that 
such studies have not suggested an involvement of chromosomal regions including genes 
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for α5 or α6 may indicate a lack of involvement of these genes in alcohol-related 
behaviours, at least in rodents (Boehm et al., 2004). In this respect, a strikingly more robust 
signal for the α5 subunit in human vs. rodent NAcc (Lingford-Hughes et al., 2012, Lingford-
Hughes et al., 2016) is intriguing and suggests that some receptor isoforms may play a 
distinct role in human addiction.  
 
A potential weakness of using the BXD mouse lines is that for those chromosomal regions 
that are identical between the C57BL/6J and DBA2/J lines, there can be no genetic variation, 
so that BXD analyses will not provide information on the involvement of such genes in 
behavioural traits. This issue has been recognised, and strategies involving multiple founder 
lines have been developed (e.g. (Williams et al., 2004)). Using a set of recombinant inbred 
mouse strains derived from eight different founder lines, no direct evidence for altered 
GABAA receptor subunit expression being associated with alcohol drinking was found (Saba 
et al., 2011). However, it was possible to identify particular SNP variations (Tabakoff et al., 
2009) that interfered with the ability of β2 subunits to interact with AP-2 adaptin protein 
that is involved in receptor internalisation (Herring et al., 2003). These observations thus 
suggest that regulation of GABAA receptor trafficking may play an important role in the 
control of alcohol consumption, despite there being little evidence for alcohol drinking 
relating to expression of GABAA receptor subunits.  
 
As far as we are aware, no studies have suggested a QTL for psychostimulant, opiate or 
cannabinoid effects that implicates GABAA receptor subunits. 
 
2.2.3 Gene deletion and mutation experiments: Drug self-administration 
 
Complementary to gene-association studies, studies employing direct manipulation of gene 
expression have also been used extensively to explore the role of GABAergic genes in 
addictive behaviours. In the following paragraphs, we will examine the impact of specific 
GABAAR genetic manipulations in mice on behaviours relevant to drug dependence with a 
focus on alcohol. Most of the literature has employed constitutive gene deletion, which may 
be confounded by compensatory plasticity of GABAergic signalling and of other genes. For 
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instance, the α6 knockout increases expression of a K+ channel that increases tonic 
inhibition (as do α6-GABAARs in cerebellar granule cells) (Brickley et al., 2001).  
 
 
2.2.3.1 alpha1.  
α1-subunit null mutant mice have been reported to show decreased alcohol and saccharin 
consumption, increased aversion to alcohol, and a marked stimulation of motor activity 
after injection of alcohol (Blednov et al., 2003b, Blednov et al., 2003a, Boehm et al., 2004). 
In keeping, mice lacking the α1 subunit showed marked reductions in both alcohol and 
sucrose-maintained operant responding, and home-cage alcohol drinking (June et al., 2007). 
In the June et al study, the null mutants also showed significant increases in locomotor 
behaviour (confirming Blednov et al’s (2003) findings) after injections of low–moderate 
alcohol doses (1.75–3.0 g/kg), an effect that could be attenuated by the dopamine (DA) D2R 
antagonist, eticlopride, and the D1 antagonist, SCH 23390, at doses that themselves did not 
affect activity. These data suggest that the α1-GABAAR may play an important role in 
alcohol-motivated behaviour, but also in operant responding for a conventional reinforcer 
(sucrose). Deleting the α1 subunit also appeared to unmask alcohol's stimulatory effects, by 
a mechanism related to DA-dependent mechanisms. Notably, deletion of the α1-subunit has 
been reported to result in a substantial (approximately 38%) compensatory increase in 
GABAA receptor α2 and α3 subunit expression (Vicini et al., 2001) and immunoprecipitation 
(approximately 50%) (Sur et al., 2001), and it is therefore unclear whether the behavioural 
effects of the deletion may reflect changes in these receptors, rather than being a direct 
consequence of α1-subunit deletion. Nevertheless, in knock-in mice with Ser270 to histidine 
and Leu277 to alanine mutations in the α1 subunit (which may alter their response to 
alcohol, without affecting normal GABAergic transmission), alterations in specific alcohol-
induced behavioural effects, but not in alcohol consumption, or place preference 
conditioning have been reported (Werner et al., 2006).  
 
Experiments attempting to localise these effects of α1 deletion to specific brain areas, 
employed siRNA to suppress α1 gene expression in ventral pallidum of high-alcohol drinking 
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rats, and found a marked decrease in binge drinking; importantly, binge sucrose drinking, or 
water intake were unaffected (Yang et al., 2011).  
 
A recent study examined cocaine self-administration, using Cre-expressing lentiviruses 
infused during early adolescence into the medial prefrontal cortex of floxed Gabra1 mice to 
delete α1-expressing genes in this area (Butkovich et al., 2015). Such mice were slower to 
learn a discriminated nose-poke response to obtain intravenous infusions of cocaine, 
though following training they achieved similar infusion rates to controls. Following 
extinction (in which the knockdown resembled controls) the mice were tested for cue-
induced reinstatement of responding, a measure which resembles instrumental responding 
for a conditioned reinforcer (Stephens et al., 2010), but the groups did not differ in this 
respect.  
 
Butkovich et al., (2015) then asked whether the slower rate of acquisition of cocaine self-
administration following Gabra1 knockdown might reflect impaired ability to learn the 
association between the instrumental response and the cocaine reinforcer. Using a task in 
which mice were initially trained to perform two different responses to obtain food 
reinforcers, one of the responses was dissociated from food delivery (which was made 
random, and thus independent of the instrumental response). While control mice now 
biased their responding to the contingent response that continued to deliver food, the 
Gabra1 knockdown mice persisted in performing both responses, suggesting an impairment 
in action-outcome learning. However, when similar manipulations were carried out in 
adulthood, the Gabra1 knockdown mice did not differ from controls in distributing their 
responses to the reinforced response. Thus, a healthy medial prefrontal cortex (PFC) α1-
GABAA receptor tone may be necessary in developing goal-directed decision-making 
strategies, but not in performing them. A parallel report from the same group (Swanson et 
al., 2015) suggests that orbitofrontal PFC GABAA α1 silencing similarly impairs the 
performance of goal-directed response strategies. Mice with orbitofrontal PFC-targeted 
GABAA α1 knockdown were unable to select actions based on their consequences, 
developing instead habit-like behavioural inflexibility. Thus cortical α1 GABAA receptors 
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appear to be important in instrumental learning and test flexibility, though it is unclear 
whether these aspects may be general to all reinforcers, and not only to drugs of abuse.  
 
2.2.3.2 alpha2 
 
Given the evidence implicating the GABRA2 gene, encoding the α2 subunit, in human 
addictions, a number of studies have investigated either consumption, or operant self-
administration of abused drugs in animals with deletions of this receptor. We found no 
evidence that α2 knockout mice differed from wild type (WT) mice when lever-pressing to 
receive increasing concentrations of alcohol on an FR4 schedule of reinforcement (four lever 
presses required to obtain one reward); both WT and knockout mice self-administered 
alcohol at similar rates, with no differences in the numbers of reinforcers earned (Dixon et 
al., 2012).This observation suggests that alcohol reinforcement does not require α2-
containing GABAA receptors. However, the ataxic and sedative effects of alcohol were 
markedly enhanced in the knockout mice, indicating that α2-GABAA receptors may play a 
part in the ability of alcohol to induce ataxia. Curiously, another report (Boehm et al., 2004) 
indicates that α2-deletion may protect against alcohol-induced ataxia. The reasons for this 
apparent discrepancy are not understood, but it may be important that although both sets 
of mice had been derived from the identical founder mutants, those in the Boehm et al 
study had been backcrossed to C57BL/6J, while those in our study (Dixon et al., 2012) were 
maintained on a mixed C57BL/6J x Sv129/ev  background.  
 
Self-administration of cocaine was also unaltered in α2 KO mice (Dixon et al., 2014); in an 
extensive dose-response study, WT, KO and heterozygous mice did not differ in their ability 
to acquire operant intravenous self-administration of cocaine, or in the ability of a priming 
dose of cocaine, or cocaine-associated stimuli to reinstate self-administration after a period 
of extinction. These observations suggest strongly that α2- GABAA receptors are not 
necessary for the reinforcing properties of either cocaine or alcohol. 
 
On the other hand, Blednov and colleagues (Blednov et al., 2011) did find effects of 
mutating α2 subunits (serine 270 to histidine and leucine 277 to alanine mutations) that 
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made them insensitive to potentiation by alcohol yet retained normal GABA sensitivity. 
These mutant mice showed a complete loss of the motor stimulant effects of alcohol, and 
also demonstrated complex changes in alcohol intake and preference the direction of which 
depended upon the exact nature of the test. These studies demonstrate that the effects of 
alcohol at GABAergic synapses containing the α2 subunit may be important for specific 
behavioural effects of alcohol putatively relevant to alcoholism. 
 
2.2.3.3 alpha5  
 
Two other studies have investigated the role of GABAA receptor subunits in alcohol self-
administration. α5 knockout mice did not differ from WTs in operant responding for 
10% alcohol/10% sucrose, but responded less for 10% sucrose (Stephens et al., 2005). The 
benzodiazepine site inverse agonist, Ro 15-4513, has high affinity for GABAA receptors 
containing the α5 subunit (see Section 2.1.3). This drug dose-dependently reduced lever 
pressing for alcohol/sucrose in WT mice, but had less effect in α5 knockout mice; lever 
pressing for sucrose was unaffected (Stephens et al., 2005). These data suggest that α5-
GABAA receptors are not essential for alcohol reward, but the reduction of operant 
responding for alcohol by Ro 15-4513 may be mediated by α5--GABAA receptors. In 
measures of alcohol consumption, α5 knockout mice did not differ from WT at 
low alcohol concentrations (2-8%), but consumed less alcohol at higher concentrations; 
these differences were probably not attributable to increased behavioural disruption of the 
knockout by alcohol, since no differences were seen in sensitivity to alcohol's sedative or 
ataxic effects. However, the ability of Ro 15-4513 to reduce alcohol consumption was 
unaffected, suggesting that this effect is not mediated by the α5-GABAA receptors. In the 
same study, the ability of a novel α5-efficacy-selective benzodiazepine receptor ligand, 
alpha5IA-II, that possesses greater inverse agonist activity at α5- than at α1-, α2- or α3-
containing GABAA receptors, to influence operant responding was studied. Alpha5IA-II (0.03-
3 mg/kg) dose-dependently decreased lever pressing for 10% alcohol, the minimally 
effective dose of 1 mg/kg, corresponding to over 90% receptor occupancy, but did not affect 
lever pressing for 4% sucrose. Although inverse agonists acting at α5-GABAA receptors 
reduced alcohol self-administration, the evidence from this study indicates that it is unlikely 
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that alcohol reinforcement in mice requires activation of α5-GABAA receptors (Stephens et 
al., 2005). 
 
A similar conclusion regarding the potential efficacy of inverse agonists in reducing alcohol 
consumption is provided by (Ruedi-Bettschen et al., 2013). Using rhesus monkeys, this 
group trained animals to self-administer 6% alcohol sufficient to reach pharmacologically 
relevant blood alcohol levels ranging from 90 to 160 mg/dl, and which produced changes in 
behaviour typical of alcohol intoxication. Concentrations of 0.3 to 3% sucrose also reliably 
maintained self-administration. The α5-GABAA receptor agonist QH-ii-066 enhanced, and 
the α5-GABAA receptor inverse agonist L-655,708 inhibited, alcohol-, but not sucrose-
drinking. The changes in alcohol drinking could be reversed with the α5-GABAA receptor 
antagonist XLi-093. 
 
2.2.3.4 α4 and δ subunit containing receptors. 
 
A number of studies have used the atypical benzodiazepine, Ro 15-4513, to investigate the 
function of α4-GABAARs in alcohol related behaviours. This drug was initially characterised 
as an ethanol antagonist, and was thought to achieve this effect via an action at α4/6βδ-
GABAARs, putatively involved in the actions of ethanol (Hanchar et al., 2006, Wallner et al., 
2006); but see (Korpi et al., 2007) for detailed discussion). Some evidence in keeping with 
this interpretation is provided by data indicating that the ability of Ro 15-4513 to antagonise 
ethanol-induced ataxia is absent in α4 knockout mice (Iyer et al, 2011), though, curiously, 
the effect was seen only in male mice. However, approximately 90% of high affinity Ro 15-
4513 binding is lost in the brains of mice rendered insensitive to this atypical BZ ligand by a 
point mutation in the γ2 subunit (F77I), and, moreover, Ro 15-4513 binding is prominent in 
regions devoid of δ subunit expression (Linden et al., 2011). Thus, the data of Iver et al 
2011) may not reflect the involvement of α4βδ receptors, but instead may possibly involve 
adenosinergic transmission (Meng and Dar, 1994).   
 
More persuasively, alcohol intake was lowered in mice carrying a constitutive knockout of 
the δ-subunit, and these animals also showed attenuated withdrawal from chronic alcohol 
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exposure (Mihalek et al., 2001). It is of interest that these effects could be dissociated from 
a normal anxiolytic response to alcohol and a normal hypothermic response to alcohol, and 
the knockout mice developed both chronic and acute tolerance. 
 
As mentioned already, constitutive knockout mice provide a blunt instrument for analysing 
the contribution of genes to behaviour, as the gene is absent during development 
(potentially allowing compensatory changes in expression of other genes), as well as being 
effective in all parts of the brain. More recently, techniques have been developed that allow 
gene manipulation in adulthood, as well as limiting the manipulation to discrete brain areas, 
or to specific neuronal classes. Nie and colleagues used the technique of virally-mediated 
RNA interference (RNAi) to reduce expression of the GABAA receptor δ-subunit in adult rats 
in localized regions of the NAcc to test the hypothesis that δ-subunit-containing GABAA 
receptors in the NAcc are necessary for oral alcohol consumption. They found that 
knockdown of the δ-subunit in the medial shell region of the NAcc, but not in the ventral or 
the lateral shell, or in the core, reduced alcohol intake. In contrast, δ-subunit knockdown in 
the medial shell did not affect intake of a 2% sucrose solution, suggesting that the effects 
of GABAA receptor δ-subunit reduction are specific to alcohol (Nie et al., 2011). In a variety 
of neurons (e.g. thalamocortical neurons, hippocampal dentate gyrus granule cells) the δ 
subunit associates with the α4 subunit and a β subunit to form extrasynaptic receptors 
(Herd et al., 2013, Peden et al., 2008). Indeed, in mouse NAcc medium spiny neurons 
(MSNs), using both immunohistochemistry and electrophysiology, we demonstrated the 
presence of extrasynaptic α4βδ receptors, that are activated by ambient concentrations of 
GABA to mediate a tonic inhibitory current that reduces neuronal excitability (Maguire et 
al., 2014). 
 
In keeping with this association of alcohol drinking with α4-GABAA receptors, Rewal et al 
(2012) further showed that virally-mediated RNAi that transiently reduced expression of the 
α4 GABAA subunit, also significantly reduced responding for alcohol after α4 reductions in 
the NAcc shell, but not in NAcc core. This reduction was specific to alcohol, as responding 
for sucrose was again not altered. Interestingly, responding during reinforced sessions was 
not altered during the initial 5 minutes of the session, but decreased after 5 minutes, 
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following multiple reinforced responses (Rewal et al., 2012), suggesting that the 
manipulation did not alter initial motivation for alcohol.  
 
The drug gaboxadol, when used at appropriately low concentrations, acts as a selective 
agonist of extrasynaptic GABAA receptors containing the δ subunit (Belelli et al., 2005). In 
apparent disagreement with the observations made on the α4 and δ subunit gene 
interference studies (Ramaker et al., 2012) found in C57BL/6J mice that gaboxadol dose-
dependently decreased alcohol intake in both two-bottle choice, and limited access 
paradigms, altering both the consumatory and appetitive processes of operant self-
administration as well as shifting the drinking patterns in both procedures. In a subsequent 
study, the same group (Ramaker et al., 2015) found that gaboxadol infused into NAcc shell, 
decreased consumption of 10% alcohol in a limited access test. Thus, inactivating 
extrasynaptic tonically-active receptors using viral knockdown reduces alcohol consumption 
(Nie et al., 2011, Rewal et al., 2012), while facilitating their function with gaboxadol also 
decreases alcohol intake (Ramaker et al., 2012, Ramaker et al., 2015). Ramaker and 
colleagues suggest two potential explanations of these apparently incompatible data sets; 
firstly, gaboxadol at high doses is not specific for α4βδ receptors, and it is difficult to 
estimate local concentrations in experiments using intra-striatal infusions; secondly, dose-
response functions for alcohol consumption frequently exhibit an inverted-U shape, so that 
shifts either to the left or right of the optimal may result in decreased consumption. A 
further possible account is that in the case of gaboxadol infusions, receptor desensitisation 
may occur, which would not be the case for the knockdown. We are not aware of data that 
could throw light on these hypotheses. In contrast to the NAcc injections, administration of 
gaboxadol into infralimbic cortex was reported to increase alcohol consumption (Fritz and 
Boehm, 2014). 
 
While this series of studies suggests strongly that extrasynaptic tonically active α4βδ GABAA 
receptors play a role in regulation of alcohol consumption, it is not clear whether they 
facilitate or reduce it. We recently investigated the potential role of tonically active 
GABAergic receptors in mediating alcohol intake, using mice with an N-ethyl-N-nitrosourea-
induced point mutation of the β1 subunit. This mutation, a leucine-to-arginine exchange 
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(L285R) in the highly-conserved third transmembrane domain (TM3), near the TM2-TM3 
linker, an important area for GABA receptor activation and ion channel gating, resulted in 
spontaneous GABAA receptor ion channel opening (i.e. in the absence of GABA) and 
increased GABA sensitivity of recombinant GABAARs, coupled to increased tonic currents in 
the NAcc (i.e., resembling tonically active receptors). A similar electrophysiological pattern 
was seen in a spontaneous mutant, Gabrb1+/P228H. Both mutants showed an increased 
consumption of alcohol (but not of sucrose, saccharine, or quinine) in a two-bottle choice 
experiment. Furthermore, the L285R mutant gave rise to persistent operant responding to 
obtain alcohol, even to intoxication; in contrast, WT mice reduced their rate of lever 
pressing, and consumption, as the session progressed (Anstee et al., 2013). The pattern of 
operant responding suggested to us that the mutation led to a failure to satiate to alcohol, 
which might correspond to the finding (Rewal et al., 2012) that virally-mediated reduction of 
α4-containing GABAA receptors showed no changes in initial responding for alcohol, but a 
more rapid decrease in responding following multiple reinforcers (i.e., suggestive of 
facilitated satiety). Thus, tonically active GABAA receptors may play a role in mechanisms 
underlying satiety to alcohol. In this context, it is of interest that intra-accumbens 
administration of the GABAA agonist, muscimol, reduced operant responding for ethanol 
reinforcement by terminating responding after a short period of time, an effect that was 
antagonised by co-administration of the GABAA antagonist bicuculline (Hodge et al., 1995). 
However, we are unaware of evidence suggesting a selective action of muscimol on tonic 
GABAergic activity.  
 
Thus, in summary, while manipulations of particular subunits of GABAARs give rise to 
behavioural alterations, most consistent effects on motivation to obtain alcohol seem to be 
exerted by modifications of tonic conductance, including by manipulation of α4βδ 
receptors.  
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2.3. Influence of abused drugs on GABAA receptor subunit expression 
 
In principle, genetically influenced predisposition to drug taking may result from differences 
in the ability to adapt to drug intake. Thus, for instance, the development of tolerance to 
drugs increases the likelihood of increasing voluntary drug intake, which may then result in 
dependence. A factor analysis (Enoch et al., 2013) revealed that distinct groups of genes, 
notably those involved in GABA synthesis and synaptic transport and members of the chr 4 
cluster, previously associated with alcohol and drug dependence in humans, are themselves 
sensitive to the effects of alcohol/cocaine. In contrast, the two factors on which the chr 15, 
chr X and most of the chr 5 subunit genes loaded were impervious to alcohol/cocaine 
effects. However, as this study was limited to mRNA expression, the findings may not 
necessarily be extrapolated to protein levels. 
 
 
2.3.1 Chronic drug exposure: alcohol, cocaine and methamphetamine  
 
Many studies have incorporated measures of mRNA or subunit peptide levels following 
chronic alcohol treatment (see review by (Kumar et al., 2009)). In general, the occurrence, 
time course and direction of changes in subunit expression varies across brain regions 
((Grobin et al., 2000). For instance, decreases in rat α1 and α4 subunit expression assayed 
by immunoblotting after two weeks of chronic exposure to alcohol have been reported 
(Papadeas et al., 2001). However, these changes were region specific; in amygdala, 
expression of both  α1 and α4 subunits was decreased by about 20%, while in the 
accumbens, although there was a decrease of 28% in α4 subunit expression, there was no 
change in α1 subunit expression; in the VTA, no changes in either α1 or α4 subunit 
expression were found. Similarly, an impressive study with cynomolgus macaques (Macaca 
fascicularis), quantified GABAA α subunit mRNAs in basolateral amygdala following 18-
month-long exposure to alcohol (Floyd et al., 2004). The α2 and α3 subunit mRNA levels 
were significantly decreased, whereas decreases in the α1 subunit expression only 
approached statistical significance, with no changes in α4 subunit mRNA levels. As 
highlighted by the authors, these adaptations in basolateral amygdala GABAA receptors are 
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similar, but not identical, to those described in rodents after a brief forced alcohol exposure 
(Papadeas et al., 2001). In agreement with the macaque data, down-regulation of α2 mRNA 
has also been found post mortem in alcoholic patients (Jin et al., 2014); of 19 GABAA 
receptor subunits investigated in the central nucleus of the amygdala, only the mRNA 
encoding the α2 subunit was significantly down-regulated in alcoholic patients compared 
with control subjects, though in the human cohort, it is not possible to deduce whether the 
lowered expression was present prior to onset of alcohol abuse.  
 
A number of additional studies also document how changes in the expression of a variety of 
GABAA receptor subunits are very much dependent on the brain region investigated (e.g. 
(Hemby et al., 2006)). Moreover, similar, albeit not identical, scenarios of varied altered 
mRNA expression pattern have been documented following chronic exposure to cocaine 
(Suzuki et al., 2000). Of specific relevance and in keeping with a role for α2-containing 
receptors in addictive behaviour, chronic treatment of rodents with cocaine results in 
decreased expression of  α2 subunits in the NAcc (Chen et al., 2007). In contrast, chronic 
cocaine treatment in mice resulted in an up-regulation of α4 mRNA specifically in D1-MSNs 
(Heiman et al., 2008) which may represent a compensatory brake that limits the effect of an 
excessive DA tone associated with prolonged exposure to the psychostimulant (see also 
section 3.2.3). 
 
Considerable evidence indicates that neurobiological responses to experimenter-
administered cocaine differ from such responses when the cocaine is self-administered by 
animals (Wolf and Ferrario, 2010), and a recent report (Wydra et al., 2013) indicates that 
GABAergic transmission in the NAcc shell is differentially affected by self-administered and 
experimenter-administered cocaine. The patterns of change in receptor function following 
cocaine changes over time, in keeping with behavioural changes indicating initial 
intensification of motivation to obtain cocaine (incubation) lasting for several weeks, before 
becoming stable, and then declining. These behavioural changes are paralleled by changes 
in the strength of AMPA receptor-mediated synaptic transmission in NAcc mediated by 
altered calcium permeability (Conrad et al., 2008, Mameli et al., 2009, Loweth et al., 2014).  
However, the alterations in excitatory transmission do not seem to be paralleled by altered 
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GABAA receptor function (Purgianto et al., 2016); although surface expression of α2-GABAA 
receptor subunits was initially increased (on the second day of cocaine withdrawal), 
suggestive of increased inhibitory tone, this change was transient and no longer detected on 
withdrawal day 25 or 48. No changes in surface expression of α1 or α4 subunits were 
observed at any time. The authors suggest that upregulation of α2-subunit expression may 
be a protective mechanism against excessive cocaine taking (Purgianto et al., 2016). This 
proposal is in keeping with Dixon et al’s (2014) observation that while WT mice reduce drug 
intake over the first few days of self-administration, α2  knockout mice do not.  
 
2.3.2 Intermittent drug exposure: alcohol 
 
Alcohol-dependent individuals often consume alcohol in bouts of excessive drinking, which 
combine high levels of alcohol during such binge episodes and experience of withdrawal, a 
pattern which has been shown to be particularly deleterious, resulting in marked changes in 
brain structure and behavioural competence (Stephens and Duka, 2008, O'Daly et al., 2012, 
Duka et al., 2003). Exposure of rodents to chronic intermittent alcohol (CIE) replicates some 
of the features of this pattern of drinking. Using this model, a series of reports combining 
electrophysiological and immunoblotting approaches have revealed a consistent and 
coordinated decrease in α1 (synaptic) and δ subunit (extrasynaptic) expression and 
increases in γ2 and α4 subunits (both synaptic) in hippocampus, accumbens and basolateral 
amygdala of CIE rats (Cagetti et al., 2003, Olsen and Spigelman, 2012, Lindemeyer et al., 
2014, Liang et al., 2014). Interestingly, a similar subunit set, namely α4βδ GABAA receptors 
appeared to be affected by chronic exposure to methamphetamine in rodents, i.e. increased 
expression (Shen et al 2013). Note, however, that the functional consequences of this 
alteration, may reverse upon subsequent withdrawal because the polarity of the Cl- 
mediated response switch from inwardly to outwardly directed as a result of alterations in 
Cl- ions transporter expression (see also section 2.3.4 on Functional alterations).  
 
2.3.3 The influence of age (development) on the effects of alcohol 
 
It is widely held that adolescent mammals are particularly sensitive to alcohol exposure, and 
that this sensitivity is especially severe when exposure is intermittent, such as occurs in 
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humans with binge drinking (Stephens and Duka, 2008, Smith et al., 2015). Recently, the 
Indiana group have reported a series of observations on altered gene expression (mRNA) in 
alcohol-preferring P rats following three weeks consumption of alcohol in a “binge” pattern, 
reaching blood levels of 100 mg/dL, over a period spanning postnatal days 28 – 49 
(McClintick et al., 2015, McBride et al., 2014, McBride et al., 2013a). Striking from this set of 
data is the diversity of responses in different tissues. Thus, these three studies found no 
changes in any GABAA receptor subunits in accumbens shell, and an up-regulation of only 
one subunit (β1) in central amygdaloid nucleus. In contrast, rats subjected to adolescent 
intermittent alcohol (AIE) exposure between postnatal day (PD) 30 and PD46 showed a 
significant reduction in the δ subunit protein levels in the absence of any changes in mRNA, 
at both 48 hours and 26 days after the last alcohol exposure (Centanni et al., 2014). The α4 
subunit protein levels were significantly reduced, but mRNA levels were increased, 26 days 
(but not 48 hours) after the last AIE exposure. The α5 subunit protein levels were not 
changed by AIE, and although α5 subunit mRNA levels were reduced at 48 hours they were 
normalized 26 days after AIE. In contrast to the effects of AIE, chronic 
intermittent alcohol (CIE) exposure during adulthood had no effect on expression of any of 
the GABAA receptor subunits examined. 
 
This limited selection of exemplar studies illustrates the complexity of the altered landscape 
of GABAA receptor isoforms within the brain of animals exposed chronically and/or 
intermittently to drugs of abuse. A common feature across studies is the sensitivity of α1, 
α4, δ and, to an increasingly documented degree, α2 and γ2 subunits to dynamic changes 
upon drug exposure.  
 
These observations are intriguing for two reasons. Firstly, the same subunit clusters appear 
affected, albeit not necessarily in the same direction, by the experience of epileptic events 
typically recorded in animal models of temporal lobe epilepsy (Scharfman and Brooks-Kayal, 
2014, Grabenstatter et al., 2014a). Thus, for example, an increase and decrease in α4- and 
α1-containing GABAARs has been consistently reported in the hippocampus dentate gyrus of 
animal models of temporal lobe epilepsy, appearing specifically prominent in cohorts of 
animals exhibiting a high frequency of seizures (Gonzalez et al., 2015). Intriguingly, such 
molecular changes are associated with a reduction in phasic (i.e. synaptic) inhibition, which 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
has been putatively assigned to an increased contribution by α4βγ2- over α1βγ2-containing 
receptors (Scharfman and Brooks-Kayal, 2014, Gonzalez et al., 2015). Such changes are 
reminiscent of those described above for animals exposed to chronic intermittent ethanol. 
Whether this putative commonality of plasticity is independent of the documented 
relationship between animals withdrawn from alcohol and their sensitivity to epileptic 
seizures (Finn et al., 1995, Stephens et al., 2001, Becker and Hale, 1993) is not known. 
However, it raises the prospect that molecular mechanisms akin to those implicated in the 
neuronal GABAAR-mediated adaptations described for animal models of temporal lobe 
epilepsy (e.g BDNF regulation of α1 and α4 subunit expression via inducible cAMP response 
element repressor (ICER) and early growth response factor (Egr3) pathways respectively, 
reviewed in (Scharfman and Brooks-Kayal, 2014)may also be relevant to drug addiction and 
could be targeted to therapeutic advantage (see see also paragraph 2.3.4 Alteration in 
GABAA R function below and Conclusion Section 5). In this regard, the observation that 
selective early inhibition of STAT3, which mediates BDNF effect upon ICER down-regulation 
of α1 expression (Grabenstatter et al., 2014b), or increased α1-subunit expression in 
hippocampus dentate gyrus via a viral-mediated delivery approach (Raol et al., 2006) 
reduces long-term seizure frequency or the number of animals experiencing spontaneous 
seizures respectively, in the pilocarpine temporal lobe epilepsy model is intriguing.  
Secondly, α4βδ GABAA receptors are known to mediate a sustained form of inhibition 
known as tonic inhibition, and increased tonic inhibition in the NAcc associates with 
increased alcohol consumption in two mouse models of increased spontaneous GABAA 
receptor channel activity (Anstee et al., 2013, Maguire et al., 2014, Rewal et al., 2012) - see 
Section 2.2.3.4). Thus, selective manipulation of this specific GABAA receptor tone may be 
exploited to therapeutic advantage. In this regard the drug DS2, which is a selective PAM of 
δ-GABAA receptors may be of interest (Wafford et al., 2009, Jensen et al., 2013), though its 
limited solubility raises issues for in vivo experiments. 
 
2.3.4 Alterations in GABAA R function. 
 
In addition to changes in the expression of specific receptor subtypes, a distinct alteration in 
GABAAR function associated with drug exposure and involving a change in the polarity of the 
Cl- flux has been described for GABAA receptors in the interneurons, but not DA neurons, of 
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the VTA. Following an initial report documenting the switch of the GABAergic signal from 
inhibitory to excitatory in the VTA of opioid-dependent rats (Vargas-Perez et al., 2009), 
Taylor and colleagues recently revealed a potentially important role played by opioid-
induced glial release of BDNF, that results in a decreased expression of the K+Cl- co-
transporter KCC2, thus causing Cl- ion net movement to become outwardly directed upon 
GABAA receptor activation, thereby giving rise to neuronal depolarisation (Taylor et al., 
2016). Importantly, the GABAergic signal is not affected in DA neurons, where an inwardly 
directed Cl- gradient appears to be maintained independent of KCC2. Intriguingly, this type 
of alteration in GABAA receptor function is not unique to drug addiction as a similar switch in 
the polarity of the GABAA receptor-mediated signals has been described for epilepsy and 
neuropathic pain models (Pathak et al., 2007, Zhou et al., 2012, Barmashenko et al., 2011, 
Kahle et al., 2016). It is therefore conceivable that similar molecular mechanisms may 
operate to trigger abnormal GABAA receptor function, most notably, phosphorylation of the 
transporter (Lee et al., 2010, Kaila et al., 2014), and thus offer an opportunity for a selective 
therapeutic targeting (Friedel et al., 2015, Kahle et al., 2016).  
 
3. GABAA receptors in the neurocircuitry of addiction 
 
A detailed discussion of the neuronal substrates implicated in drug abuse and dependence is 
beyond the scope of this review and readers are referred to comprehensive reviews on this 
topic (Silberberg and Bolam, 2015, Everitt and Robbins, 2013, Koob and Volkow, 2010). 
However, an overview of the neurocircuitry implicated in addictive behaviours will be briefly 
described to highlight specific areas of relevance to GABAA receptor function and 
pharmacological manipulation. 
 
Addictive drugs share the ability to influence the function of the mesocorticolimbic system 
implicated in mediating control over motivational aspects of complex behaviours. Within 
this neuronal circuitry (Fig 3), a central role is played by the NAcc, which receives 
information about the spatial and temporal availability and value of specific rewards, 
conveyed in the form of, primarily, glutamatergic inputs originating in specific structures, 
including the hippocampus, amygdala and cortical areas. This information is integrated in 
the NAcc with other signals mediated by DA released from neurons projecting from the 
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midbrain ventral VTA. These DA neurons have been implicated as increasing activity in 
response to unexpected events with positive valence (rewards), or decreasing activity in 
response to unexpected events with negative valence (aversive events), and rapidly 
adapting to provide the corresponding activity to environmental cues predicting such events 
rather than the positive or negative events themselves (Schultz, 2016). The NAcc encodes an 
output adjusted to the inputs received, via two classical pathways, the so-called direct 
striato-nigral and the indirect striato-pallidal routes. Within this complex neuronal 
assembly, GABA plays a fundamental role as the principal neurotransmitter utilised by 
approximately 97% of NAcc neurons (both the principal neurons, MSNs, and interneurons), 
and a variety of interneurons located in the interconnected input and output regions, most 
notably the VTA, dorsal striatum and substantia nigra (Walsh and Han, 2014, Morello and 
Partanen, 2015). Accordingly, GABAA receptors are expressed at significant locations within 
these pathways (Fig 3), offering a point of regulation for neuronal function and, thereby, 
specific behavioural outputs. Nevertheless, until recently, this fundamental role of GABA in 
motivational pathways had received little attention. In common with other brain circuits, 
distinct GABAA receptor isoforms are expressed within specific neuronal populations and 
cellular domains, suggesting the possibility of a spatially controlled regulation of GABAA 
receptor function in the motivational neurocircuitry. Amongst the isoforms of particular 
relevance within the context of drug addiction (see Section 2) are the functionally detected 
expression of 1) α2βγ2 isoforms within synaptic and extrasynaptic cellular domains of NAcc 
MSNs and 2) the α4βδ subtype with its exclusively extrasynaptic localization not only in 
MSNs, but also in specific populations of interneurons in the NAcc (Maguire et al., 2014). 
α1βγ2 isoforms in NAcc and dorsal striatum MSNs, and in VTA play a separate important 
role. Amongst additional receptor isoforms inferred by in situ and/or immunohistochemical 
studies, the α5βγ2 and α2βγ1 subtypes are prominent in the NAcc and amygdala (Kalk et al., 
2012, Pirker et al., 2000, Lingford-Hughes et al., 2012, Wisden et al., 1992). It should be 
noted that α2βγ2 and α1βγ2 isoforms are additionally expressed within neuronal 
populations of cortical, hippocampal and amygdala areas where they are likely to influence 
projections from these areas into striatum. A schematic, albeit not exhaustive, 
representation of the GABAA receptor isoforms within circuits of importance in addiction is 
shown in Fig 3.       
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Figure 3 
 
3.1 GABAA Receptors and Drug Reward 
 
3.1.1 Benzodiazepine self-administration  
 
Many studies of GABAA receptor subtypes and reward have been motivated by the need to 
evaluate abuse potential of novel compounds in development for therapeutic use in 
humans. In particular, drugs acting at the benzodiazepine binding site of GABAA receptors 
have a reputation for abuse, which potentially may be attributable to an action of such 
substances at particular subtypes of GABAA receptor. The group of James Rowlett has made 
a particular contribution to this area.  
 
The mechanisms underlying the abuse-related effects of benzodiazepines are not well 
understood, and may represent a quite different type of drug abuse from psychostimulants, 
opiates, or alcohol. However, several studies suggest α1 subunit-containing GABAA 
receptors to have a critical role.  
 
The availability of novel compounds that vary with respect to intrinsic efficacy at α2, α3, and 
α5 subunit-containing GABAA receptors but lack efficacy at α1 subunit-containing GABAA 
receptors ('α1-sparing compounds') has allowed investigations of their differential ability to 
maintain intravenous self-administration (Shinday et al., 2013, Rowlett et al., 2005). These 
compounds included zolpidem, which shows preferential binding to α1-GABARs; L-838,417 
(functional selectivity for α2, α3 and α5--GABAARs), and nonselective conventional 
benzodiazepines. In a complex series of findings, the group concluded that stimulation of 
α1-GABAARs is sufficient, but not necessary, for mediation of the abuse potential of these 
drugs. In a second experiment, two groups of monkeys were used, one previously trained to 
self-administer midazolam and the other cocaine. The α1-sparing compounds were self-
administered significantly above vehicle levels in monkeys trained under a midazolam 
baseline, but not under a cocaine baseline over the dose ranges tested. Importantly, TP003 
(a compound with some functional selectivity for α3-containing receptors) had significant 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
reinforcing effects, albeit at lower levels of self-administration than non-selective 
benzodiazepine receptor agonists. The authors suggest that α1 subunit-containing GABAA 
receptors may have a role in the reinforcing effects of benzodiazepine-type compounds in 
monkeys with a history of stimulant self-administration, whereas α3 subunit-containing 
GABAA receptors may be important mediators of the reinforcing effects of benzodiazepine-
type compounds in animals with a history of sedative-anxiolytic/benzodiazepine self-
administration. While these studies suggest that different GABAA -receptors (and hence 
neural systems) may be involved in psychostimulant and benzodiazepine reinforcement, it is 
worth noting that TP003 may also possess significant activity at α1-GABAARs (Peden et al., 
2008). 
 
3.2 GABAA Receptors and processes associated with reward-seeking 
 
Although animal self-administration studies possess considerable “face validity” for human 
drug abuse, they fail to consider many aspects of behaviour and brain function that may 
contribute to drug abuse and addictive behaviour in humans. Indeed, although thus far we 
have treated addiction more or less as a unitary concept, it is clear that many different 
psychological constructs, and their underlying brain mechanisms contribute to drug abuse, 
and to drug dependence. Furthermore, addictions to different drugs may involve rather 
different brain processes, while, as it has already been hinted, addiction to a single drug like 
alcohol may come about in different ways. Clearly, then, genetic makeup may contribute in 
many different ways to the development of addiction. A more profitable approach may thus 
be to consider genetic contributions to different aspects of addiction-related behaviour, 
only some of which may contribute to any single individual’s addiction. 
 
 A very general model of drug abuse mechanisms holds that we need to consider two broad 
classes of psychological function, one of which concerns motivation to obtain drug (resulting 
from the intrinsic “rewarding” nature of the drug, memory of past experience with the drug, 
and current motivational state (e.g. deprived vs. satiated)) while the output of this system is 
subject to control by higher order functions (low impulsivity, restraint, etc. (see Fig 4 and 
(Volkow et al., 2004)). Clearly even within such an oversimplified system, gene variations 
might contribute in a very large number of ways to the behavioural output. 
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In the next section we will consider different aspects of the overall system, and the extent 
to which current knowledge allows us to impute functional roles for GABAA genes in 
particular functions that might contribute to addictive behaviour. 
 
3.2.1 Brain stimulation reward 
It has been known since the work of (Olds and Milner, 1954) that mammals will perform 
instrumental tasks in order to deliver electrical impulses to certain brain areas (intracranial 
self-stimulation; ICSS). By definition, such electrical stimulation is reinforcing (behaviour 
preceding the stimulation is strengthened), leading to the easy (but possibly mistaken) 
conclusion that such stimulation activates areas of the brain integral to the perception of 
“reward”. It has been known for decades that areas within, or interacting with brain DA 
pathways, are especially likely to support ICSS (Crow, 1972), and that drugs that facilitate 
transmission in DA pathways (amphetamines, cocaine, etc) also facilitate performance for 
intracranial self-stimulation (Phillips and Fibiger, 1973, Herberg et al., 1976). Less well 
understood are observations that drugs facilitating transmission at GABAA receptors (i.e. 
benzodiazepine receptor ligands) possess similar properties in enhancing ICSS (Herberg et 
al., 1986, Liebman, 1985) with comparable effect sizes (Straub et al., 2010). Diazepam and 
cocaine have opposite effects on extracellular DA in the NAcc, with cocaine increasing and 
diazepam decreasing DA concentrations (Di Chiara and Imperato, 1988, Finlay et al., 1992, 
Invernizzi et al., 1991), indicating that the mechanism of action for the “rewarding effects” 
of the two drugs may be different. Note, however, that a recent report indicates that an 
inverse agonist at benzodiazepine receptors, Ro 15-4513, is able to antagonise the 
facilitatory effects of methamphetamine on ICSS (Tracy et al., 2016).  
Rudolph and colleagues postulated that benzodiazepines might achieve their effects on ICSS 
by interacting with accumbal GABAA receptors expressing α2 subunits, and showed that 
diazepam-facilitation of ICSS was indeed absent when α2-containing receptors were made 
insensitive to benzodiazepines (α2(H101R) mice) (Reynolds et al., 2012). Indeed, reward 
thresholds at the highest dose of diazepam in these animals, was increased, which the 
authors interpreted to mean that diazepam may even be aversive without the positive 
modulation of the α2-GABAA receptors. However, preventing benzodiazepine sensitivity at 
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α2-GABAA receptors was not unique in altering ICSS reward thresholds, and the 
corresponding manipulation of α3 also abolished the effects of diazepam, while diazepam’s 
effects in α1(H101R) mice were reduced.  On the basis of previous work showing that α2-
GABAA receptors makes a significant contribution to GABAergic inhibition in NAcc (Dixon et 
al., 2010), Rudolph and colleagues attribute the involvement of the α2 subunit to its 
participation in GABAergic transmission in NAcc, while the action of diazepam at α1-GABAA 
receptors in ventral tegmental area (Tan et al., 2010) is speculated to explain the 
effectiveness of the α1(H101R) manipulation. 
In a subsequent report (Engin et al., 2014), the Rudolph group confirmed that another 
benzodiazepine, midazolam, also failed to facilitate ICSS in α2(H101R) mice. These animals 
also consumed less midazolam than WT mice when it was presented with sucrose in a two-
bottle choice experiment, consistent with loss of midazolam’s rewarding effects (or its 
ability to facilitate the rewarding properties of sucrose) in the mutant mice. In an important 
further step, this latter effect was also found in mice in which α2 had been deleted 
specifically in accumbens, using virally-mediated knockdown. These findings imply that α2-
GABAA receptors in the NAcc are involved in at least some reward-related properties of 
benzodiazepines. 
 
3.2.2 Dissecting “reward”  
The VTA projections to the NAcc, and associated neural circuits are often referred to as 
“reward” pathways, though it is frequently unclear what particular function is being 
ascribed to them. In the context of explanations of drug abuse, the term “reward” is 
sometimes used as synonymous with subjective pleasure (which itself may have several 
dimensions such as feelings of euphoria, or of relaxation), sometimes as a synonym for 
occurrences that, when they follow a particular behaviour, strengthen it (i.e. reinforcers), 
while for others the term is used loosely to cover a range of more carefully defined 
psychological constructs such as “incentive” (see (Salamone and Correa, 2012) for a critical 
review). The mesolimbic DA pathways have been ascribed a central role in signalling these 
aspects, so that DA is frequently (and uncritically) referred to as the “reward transmitter”. 
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Studies of GABA function have slipped easily into this thinking, so that GABAergic influences 
in addiction are frequently considered in terms of their ability to modulate “reward”.  
 
Two more rigorous considerations of DA function are worth considering in this context. The 
first holds that a pulse of DA release occurs in the context of unexpected occurrence of 
biologically valuable events (e.g. unexpectedly obtaining a piece of food), but this pulse 
soon shifts to environmental stimuli that precede (and thus predict) such events (Schultz et 
al., 1997). In that context, DA has been referred to as a “teaching signal”, involved in 
learning associations between otherwise neutral environmental events (e.g. a dinner gong) 
and biologically valuable events (e.g. dinner), though, in reality the learning of that 
association must occur somewhere other than within the DA system, but one for which DA 
release is an important consequence. Secondly, DA release within the NAcc has long been 
proposed to energise goal-directed behaviours, i.e., to form the biological basis of certain 
aspects of motivation (see (Salamone and Correa, 2012) for a review). In keeping with that 
rough distinction, phasic DA release has been suggested to perform the “teaching signal” 
function, while tonic release may act to energise selected goal-directed behaviour (Hamid et 
al., 2016, Hart et al., 2014, Cagniard et al., 2006b, Cagniard et al., 2006a).  If this is a useful 
approach to understanding ventral striatal function, and its role in addictions, then it is 
worth considering how GABAergic systems may be involved.  
 
3.2.3 The role of GABAA receptors within mesolimbic pathways: a hub for integration of 
glutamatergic and dopaminergic signals?  
 
Current knowledge suggests that information regarding incentive cues reaches the NAcc via 
glutamatergic projections from prefrontal cortex, thalamus, hippocampus and amygdala 
that synapse on the dendrites of the GABAergic MSNs that make up 95% of NAcc neurons 
and constitute the only output from the nucleus (Tepper et al., 2008, Tepper et al., 2007). 
Under the influence of dopaminergic inputs from the VTA, these MSNs sort and prioritise 
the information provided by glutamatergic inputs and project the integrated output to basal 
ganglia output systems that express motivated behaviour. Understanding the mechanisms 
underlying this integrative process is fundamental to describing how motivations compete 
with each other for control over behaviour, yet we know little of its detailed mechanism. 
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To a considerable extent, striatal MSNs can be differentiated as expressing either the 
dopamine D1 or D2 receptors (D1R or D2R), and D1R- and D2R-expressing MSNs differ in 
their output pathways: whereas D1R-MSNs largely project directly to the VTA (direct 
pathway), synapsing onto GABAergic interneurons that themselves inhibit DA neuron cell 
bodies projecting to the NAcc, D2R MSNs project in rodents to the ventral pallidum (external 
pallidum in humans), where they serve to inhibit a further GABAergic output pathway 
projecting to the VTA (indirect pathway). [Note, this strict dichotomy has been recently 
challenged by the demonstration that, in mice, outputs from ventral (i.e. NAcc) but not 
dorsal striatum do not exhibit this strict anatomical segregation of D1R vs D2R MSNs as both 
D1- and D2-MSNs project from NAcc via the indirect pathway and similarly, both D1- and 
D2-MSNs directly innervate output neurons of the basal ganglia, thus adding a significant 
higher level of complexity (Kupchik et al., 2015). Although challenged by some reports in 
awake rodents (Mahon et al 2006), DA’s ability to modulate the glutamatergic input has 
been suggested to depend upon the state of polarisation of the MSN dendritic membrane; 
thus, DA induces further depolarisation via D1 receptors when the local membrane is partly 
depolarised by glutamatergic inputs (up-state), but has no effect, or may contribute further 
hyperpolarisation when the membrane is in the hyperpolarised “down-state” (O'Donnell 
and Grace, 1995, West and Grace, 2002, O'Donnell et al., 1999).  
 
Irrespective, the modulatory effects of DA on the glutamatergic inputs are a function of the 
receptor activated, D1R and/or D2R, with activation of D1R being usually excitatory and D2R 
usually inhibitory (Surmeier et al., 2007). DA acting through D1Rs may thus serve to increase 
the signal-to-noise ratio for glutamatergic cortical, amygdala and hippocampal inputs 
(Nicola et al., 2004). The integrated sum of such interactions across its dendritic tree will 
determine the probability of an individual MSN firing an action potential, and thus providing 
an output contributing to behaviour. Thus, variants within, and manipulation of GABAA 
receptors expressed within this circuit (See Section 3 and Fig 5) may contribute in a complex 
fashion to the function of the basal ganglia.  
 
In principle, GABAA receptors may influence the functioning of the system in several ways. 
Firstly, within the striatum, MSNs receive two types of GABAergic inhibitory inputs (Fig 5): 1) 
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a feed-forward inhibitory pathway from a range of GABAergic interneurons, amongst which 
the fast-spiking (parvalbumin-expressing) interneurons provide the strongest input with 
approximately 100 connections targeting the somata of each MSN (Koos and Tepper, 1999); 
and 2) a lateral inhibitory input largely located on the dendritic tree, through recurrent 
collaterals from neighbouring MSNs, with individual MSNs thought to receive inputs from 
about 450 neighbouring MSNs (Tunstall et al., 2002, Wilson, 2007). Of the two inputs, that 
from the fast-spiking interneurons is considerably stronger, both because of the proximal 
somatic vs. dendritic location, and because of the high degree of synchronization amongst 
fast-spiking interneurons (Tunstall et al., 2002). Thus the feed-forward inhibitory pathway 
may be best suited to influence action potential generation at the soma. On the other hand, 
lateral inhibition will strongly affect local dendritic processes including plasticity (Tepper et 
al., 2008).  
 
Importantly for the consequences of GABAAR activation, at rest MSNs exhibit a significantly 
negative membrane potential (Vm)  (approximately -85-90 mV), which is below the reversal 
potential for Cl-, meaning the net Cl- movement through GABAAR-associated channels will be 
outwards and therefore depolarising (Czubayko and Plenz, 2002, Plenz, 2003, Maguire et al., 
2014). Thus, under particular circumstances, a GABAergic signal can be excitatory, and 
facilitate action potential generation if temporally coupled with an incoming glutamatergic 
signal within an appropriate time frame (~50-60 ms; (Plenz, 2003, Bracci and Panzeri, 2006). 
Alternatively, the shunting actions of GABA will give rise to a net inhibitory effect. Transient, 
synaptic GABAergic inputs are clearly best suited to serve a potentially facilitating excitatory 
role, whereas sustained activation of an extrasynaptic GABAergic conductance will 
invariably yield a net shunting inhibitory action (Song et al., 2011). Interestingly, modelling 
studies support a role for MSNs as input integrators over a time window of 40-60 ms, 
suggesting that the synaptic GABAAR activation may fine tune the modulatory action of DA 
to increase or decrease, via D1R or D2R activation respectively, the temporal integration 
window of glutamatergic cortical and hippocampal inputs (Bracci and Panzeri, 2006, Moyer 
et al., 2007). Furthermore, the overall GABAergic effect may be dependent on the firing 
pattern of DA neurons, as phasic tonic firing would give rise to low nanomolar 
concentrations of DA and target primarily extrasynaptic sites, whereas burst firing would 
associate with micromolar concentrations of DA and would be restricted largely to synaptic 
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locations (Phillips and Wightman, 2004, Floresco et al., 2003, Arbuthnott and Wickens, 
2007). Lastly, the presence of both D1R and D2R on the presynaptic varicosities of MSNs 
(Wong et al., 1999) engenders both DA receptor types with the ability to strategically 
regulate GABAergic transmission within striatal (both dorsal and ventral) circuits (see Fig 5).  
      
Although it is established that a variety of GABAAR subunits is expressed in striatum, not 
much is known regarding the receptor stoichiometry of GABAA receptors responsive to the 
feed-forward inhibitory and lateral inhibitory projections, and whether/how they may differ 
from each other. However, our electrophysiological studies suggest that perhaps 30% of 
synaptic inhibition of MSNs is mediated by α2- GABAA receptors (Dixon et al., 2010). 
Extrasynaptic inhibition mediated by α4βδ GABAA receptors  is also prominent in the soma 
of NAcc MSNs as both the selective δ-GABAA receptor agonist gaboxadol, and DS2, a 
selective positive allosteric modulator, greatly increased the tonic current of all MSNs from 
WT, but not from δ knockout or α4 knockout mice (Maguire et al., 2014). Coupling DA and 
tonic inhibition, the acute activation of D1 receptors (by a selective D1 agonist or indirectly 
by amphetamine) greatly enhanced GABAergic tonic inhibition in D1R-MSNs but not D2R-
MSNs (Maguire et al., 2014), suggesting a potential mechanism whereby DA acting at D1 
receptors may under some circumstances (e.g. during burst firing mode resulting in high 
level of DA), acts to brake an excessive excitatory tone at somatic or, possibly, dendritic 
locations. Although as yet lacking experimental evidence, it is tempting to speculate that 
similar mechanisms to those described here for somatic regulation of MSNs, may also apply 
to their dendritic regions where high levels of α2 but also α4 and δ subunits, are also 
detected (Maguire et al., 2014). Thus, GABA and DA may interact in a dynamic and 
reciprocal fashion to provide the filtering mechanism, canonically attributed to DA, which 
supports stronger inputs at the expense of the weaker ones. A detailed understanding of the 
conditions and modalities under which such interaction will be physiologically and 
pathologically relevant will require additional experimental evidence.  
 
A second means whereby GABA may influence the mesolimbic DA pathway, is the 
GABAergic regulation of the VTA cell bodies of DA neurons projecting to ventral striatum 
(Fig 3). In this case, α1-GABAARs may play a predominant role (Tan et al., 2010) in 
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hyperpolarising GABAergic interneurons that inhibit the DA cells. Thus, facilitation of 
GABAergic transmission at α1-GABAARs may serve to facilitate DA transmission by indirect 
disinhibition (Lees et al., 2012). Although it is generally observed that drugs such as 
benzodiazepines that facilitate GABAergic inhibition decrease DA turnover in accumbens (Di 
Chiara and Imperato, 1988, Finlay et al., 1992, Invernizzi et al., 1991), fast-scan cyclic 
voltametry studies have shown that activation of GABAARs by direct administration of the 
GABAAR agonist muscimol into the VTA significantly increased DA release in the NAcc (Xi and 
Stein, 1998). However, this interpretation is subject to further complexity as under specific 
circumstances, GABAA receptors may contribute to depolarisation at presynaptic locations 
(Trigo et al., 2008). In keeping with this possibility, muscimol acting at α4βδ receptor 
isoforms presynaptically increased the GABAergic input to the VTA, thus potentially 
reducing DA input to the NAcc (Xiao et al. 2007). Thus, the net effect of facilitating 
GABAergic inputs to VTA may be function of the combined or selective activation of 
different receptor isoforms. The outcome of such complex interactions for DA projections to 
NAcc, and for behaviour, will thus be difficult to predict. 
 
Lastly, GABA release from VTA synapses in the striatum will tonically inactivate interneurons 
(TANs), that employ acetylcholine as their major transmitter (but also co-release glutamate). 
Although few in number, the extensive connections of TANS may allow them considerable 
influence over MSN activity, so that control of their activity by GABAergic inputs may play an 
important role in determining final outputs (Brown et al., 2012). 
 
A major task is now to integrate this emergent understanding of GABAergic function in the 
striatum into our understanding of the role of GABAA receptors in addictive processes. 
 
3.2.4 Striatal GABAA receptors and conditioned reward 
 
The location of several subtypes of GABAA receptors in pathways known to play a role in 
motivational learning raises the possibility that they may play separate roles, potentially 
allowing specific manipulation of different aspects of motivated (and addictive) behaviour. 
We consider these possibilities in the next section. 
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3.2.4.1 alpha1 
 
Only a limited number of studies appear to have investigated the role of α1 subunits in 
reward-related behaviour.  
 
As outlined above, deficits in action-outcome association learning (i.e., the ability to learn 
which particular responses are required to obtain specific rewards) are found in mice with 
various discrete depletions of the α1 subunit in prefrontal cortex, consistent with known 
effects of lesions in these areas (Butkovich et al., 2015, Swanson et al., 2015).  We are 
unaware of studies investigating the role of other GABAA receptor subtypes on reward and 
motivation in similar models, though these would be extremely valuable.   
 
In a less-well defined measure of reward learning, the ability of cocaine to support 
conditioned place preference (CPP) was unaltered in the α1 knockout mice (Reynolds et al., 
2003a) despite the psychostimulants cocaine and d-amphetamine failing to induce 
hyperlocomotion in α1knockout mice. Intriguingly, using a rat CPP model, Jiao and 
colleagues have revealed a selective transient down regulation of the α1 (but not α2) 
subunit in the dorsal striatum (but not PFC, amygdala or hippocampus) of rats place-
conditioned to methamphetamine; control rats in which drug administration was not 
conditioned to the place did not show such changes. These findings suggest a role for α1-
GABAA receptors in the formation of drug reward memory and, in agreement, intra-(dorsal) 
striatum administration of the selective α1- GABAAR PAM, zolpidem before pairing  was able 
to prevent methamphetamine-induced CPP formation (Jiao et al., 2016). Collectively, the 
study highlights an important role for α1-GABAA receptors in the dorsal striatum in the 
formation of reward-environment associations. Yet, it remains to be addressed how a 
history of exposure to different type of addictive drugs e.g. opiates vs. cocaine, may interact 
with subsequent pharmacological manipulations of selective GABAAR isoforms (see (Shinday 
et al., 2013)).  
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3.2.4.2 alpha2 
 
Since DA projections to ventral striatum exert their influence on behaviour by interacting 
with the major GABAergic projection neurons, it is worth considering what aspects of those 
functions ascribed to DA may be affected by modulating striatal GABAergic receptors.  
 
That animals readily learn that arbitrary environmental stimuli can be used to predict the 
forthcoming availability of food, and adapt their behaviour accordingly, is a classic example 
of Pavlovian conditioning, and forms the basis of the “teaching signal” hypothesis of DA 
function mentioned above. Thus, if an arbitrary light stimulus (cue) is illuminated shortly 
before food is delivered into a receptacle, hungry rodents soon approach the receptacle at 
light onset, without waiting for food delivery (so-called discriminated approach, or goal 
tracking). In keeping with the teaching signal hypothesis, 6-hydroxydopamine lesions of the 
NAcc, leading to approximately 80% reductions in tissue DA, profoundly impair 
discriminated approach regardless of whether the lesion is made prior to, or subsequent to 
training (Parkinson et al., 2002).  In contrast, mice with constitutive knockout of α2 subunits 
of GABAA receptors show no impairment in acquiring discriminated approach (Dixon et al., 
2010), strongly suggesting that these receptors are not involved in motivational learning.   
 
Once animals have learned the association between the cue and food delivery, they will 
learn an arbitrary instrumental response that activates the cue (without activating food 
delivery).  Thus the arbitrary cue has acquired reinforcing properties of its own as a 
consequence having been paired with food availability. This phenomenon is known as 
conditioned reinforcement, and again, manipulations that interrupt DA function in ventral 
striatum disrupt the behaviour (Beninger and Phillips, 1980) while drugs that facilitate DA 
neurotransmission facilitate it (Kelley and Delfs, 1991a, Kelley and Delfs, 1991b). Again in 
contrast to the effects of DA manipulations, constitutive deletion of α2 receptors has no 
effect on conditioned reinforcement (Dixon et al., 2010, Duka et al., 2015). Thus, GABAA 
receptors incorporating the α2 subunit, despite their important contribution to decreasing 
MSN excitability, appear not to play a role in the “teaching signal” aspects of DA receptor 
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function. Furthermore, another measure of “conditioned reward”, CPP to cocaine, also 
shows no impairment in α2 knockout mice (Dixon et al., 2010). Although interpretation of 
CPP experiments can be complex (Stephens et al., 2010), in keeping with a lack of effects of 
the deletion on reward-associated learning, α2 knockout animals do not differ from WT 
mice in learning an operant response to obtain food (Dixon et al., 2014, Dixon et al., 2012), 
or cocaine (Dixon et al., 2014), or alcohol (Dixon et al., 2012).  
 
In contrast, α2-GABAA receptors seems to play an important role in the energising aspects 
of DA; as already mentioned, psychostimulant drugs facilitate instrumental responding to 
obtain conditioned reinforcers, but both cocaine (Dixon et al., 2010) and methylphenidate 
(Duka et al., 2015) fail to increase lever pressing, or nose-poking by α2 knockout  mice for 
conditioned reinforcers. Perhaps related to this, while psychostimulants show a normal 
ability to increase locomotor activity in α2 knockout mice, they do not give rise to 
behavioural sensitisation to repeated administration of the drug (Dixon et al., 2010, Morris 
et al., 2008). Both psychostimulant-facilitation of conditioned reinforcement and 
behavioural sensitisation may reflect an interaction of psychostimulants with conditioned 
behaviours, and both phenomena are hypothesized to contribute to drug abuse by 
facilitating incentive learning (Parkinson et al., 1999, Robinson and Berridge, 1993, Le 
Merrer and Stephens, 2006).   
 
 
In keeping with a role for α2 subunits in behavioural sensitisation, selective activation of α2-
GABAA receptors, achieved using Ro 15-4513's agonist properties in α2(H101R) mice, 
facilitated the stimulant effects of cocaine, and induced behavioural sensitisation in its own 
right, such sensitisation showing cross-sensitisation to cocaine (Morris et al., 2008). 
Importantly, the stimulant effects of Ro 15-4513 in the α2(H101R) mice were also seen 
when the drug was infused into the ventral striatum, suggesting strongly that these effects 
were attributable to α2-GABAA receptors in this region. While the experiments in 
constitutive knockout mice do not inform us regarding the precise area in which α2-GABAA 
receptors are important, the effectiveness of drug injection into the ventral striatum 
suggests that not only are α2-GABAA receptors appropriately located in ventral striatum to 
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influence addiction-related behaviours, their manipulation influences the motivational 
consequences of cocaine. Thus, α2-GABAA receptors may be involved in the facilitation of 
conditioned drug-seeking by psychostimulant drugs although at present it is not known 
whether they may serve distinct functions in D1 vs  D2 MSNs  as appears to be the case  for 
α4-GABAA receptors (see section 3.2.4.3 below).  
 
3.2.4.3 alpha4 
Similar to the constitutive α2 knockout mice, α4 knockout mice do not differ from their WT 
littermates in learning to approach the food chamber following the onset of a predictive cue 
(Macpherson et al., 2016). Similarly, both α4 knockout and WT mice accurately learned to 
elicit presentation of the cues via nose-poke responding, thus demonstrating robust 
conditioned reinforcement. However, in comparison to their WT counterparts (and in 
contrast to α2 knockout mice), α4-knockout mice displayed higher levels of instrumental 
responding, suggesting they were more highly motivated to obtain the conditioned 
reinforcer. Administration of cocaine dose-dependently potentiated instrumental 
responding for the conditioned reinforcer equally across both genotypes, the heightened 
level of responding in the α4 knockout mice being maintained across the cocaine doses 
(Macpherson et al., 2016), suggesting that tonic GABAergic inhibition of MSNs may normally 
serve to inhibit motivation to obtain conditioned reinforcement. However, when 
α4βδ receptors of WT mice were activated by local infusion of the α4βδ-preferring agonist, 
gaboxadol, into the NAcc, no effect on responding for the conditioned reinforcer was seen, 
though this treatment reduced cocaine potentiation of responding for conditioned 
reinforcers in WT (but not α4 knockout- mice). 
 
That these observations resulted from α4 deletion specifically in ventral striatum was shown 
by infusion of an Ad-shα4 adenovirus, but not an adenovirus carrying a scrambled sequence, 
directly into ventral striatum (Macpherson et al., 2016); as with constitutive knockout mice, 
control and α4-subunit viral knockdown mice demonstrated an equal ability to learn the 
food-predictive properties of the CS+. Similarly, the α4-subunit viral knockdown mice 
showed increased instrumental responding for the conditioned reinforcers relative to 
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controls, providing further evidence that α4-GABAA receptors specifically within the NAcc 
are involved in mediating instrumental responding for reward-conditioned cues.  
 
Finally, specific deletion of the α4-subunit from DA D2R-expressing cells (α4D2 knockout 
mice), but not from D1R-expressing cells (α4D1 knockout mice), mimicked the phenotype of 
the constitutive knockout, potentiating CRf responding and blocking intra-accumbal 
gaboxadol attenuation of cocaine-potentiated CRf responding. These data demonstrate that 
α4-GABAA receptor-mediated inhibition of D2R-expressing neurons reduces instrumental 
responding for a conditioned reinforcer and its potentiation by cocaine. Importantly, 
impairing transmission at α4-GABAARs in constitutive α4 knockout mice (Macpherson et al., 
2016) or by viral knockdown in rats (Rewal et al., 2012) did not affect responding for 
conventional reinforcers, while responding for alcohol was decreased following virally-
mediated knockdown (Rewal et al., 2012). 
 
These data suggest some similarities, and some differences in the functions of α4 and α2-
GABAA receptors. Deletion of neither subtype had consequences for the animal’s ability to 
learn the association between the CS and food reward, suggesting that α4, like α2, is not 
involved in the prediction error/teaching signal function of the striatum. However, unlike α2 
subunit deletion, suppression of α4 subunit expression had no consequences for the ability 
of cocaine to increase responding; instead, the deletion was itself sufficient to facilitate 
responding for the conditioned reinforcer. Since similar effects were found when the 
deletion was limited to D2R-expressing neurons, it appears that α4-GABAA receptor-
mediated inhibition of D1-MSNs was not involved in determining the strength of response 
for the conditioned reinforcer.  
 
Like α2 knockout mice, constitutive α4 knockout mice did not differ from WT in their 
expression of cocaine-CPP (Maguire et al., 2014). However α4D1 knockout mice showed 
facilitated cocaine-CPP (Maguire et al., 2014). Furthermore, the α4βδ agonist, gaboxadol, 
administered systemically, or directly into the NAcc of WT, but not α4 knockout or α4D1 
knockout mice, blocked the ability of cocaine, administered during the test phase, to 
enhance CPP. In contrast, α4D2 knockout -mice exhibited normal CPP, but no cocaine 
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enhancement (Maguire et al., 2014). These findings are complex, particularly in the light of 
the recent report demonstrating the segregation of D1R and D2R MSNs to the direct and 
indirect output pathways to be no longer valid for the mouse NAcc (Kupchik et al., 2015). 
Nevertheless, collectively, these observations suggest that α4-GABAA receptor-mediated 
tonic inhibition of D1R-MSNs serves to weaken the ability of cocaine to facilitate motivated 
behaviour, while similar inhibition of D2R-MSNs has little effect. 
 
In conclusion, interactions between DA and GABAergic tonic inhibition of D1R- and D2R-
MSNs provides an intrinsic mechanism to differentially affect their excitability in response to 
psychostimulants and thereby influence their ability to potentiate conditioned reward.  
 
 
3.2.5 Integrating GABAergic molecular and reward-related behavioural dysfunctions 
 
Determining the role of GABAA receptor-mediated signalling in the striatum has proved 
challenging because the currently available experimental approaches cannot adequately 
access the ensembles of the complex striatal network and their response to the cortical 
inputs. However, because of the knowledge gained from studies of both the anatomical 
connections, and the individual conductances at the single cell level, an increasing number 
of attempts have been made to model how these factors may interact at a network level. A 
very recent investigation, utilising such a modelling approach has resulted in a better 
understanding of the putative roles of lateral inhibition and feed-forward inhibition (Moyer 
et al., 2014). From the modelling perspective, the specific task of lateral inhibition would be 
to confer timing precision in the response of the neuronal ensembles to incoming 
coordinated inputs, by silencing the activity of those MSNs that are not synchronised. In this 
way, lateral inhibition could also constrain the gain of the network even when there is a 
significant increase in inputs. Feed-forward inhibition would aid this task by specifically 
targeting inhibition of the non-synchronised, over the synchronised MSNs. Intriguingly, 
feed-forward inhibition would be most effective when fast-spiking interneurons are, 
themselves, desynchronised, possibly because desynchronised firing would afford a larger 
window for inhibition. This proposal is consistent with the long-held view that striatal 
function is competitive in nature, but also reveals the importance of the latency of the 
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ensembles responses (rather than the size of the ensembles) in establishing the MSN 
ensemble “winner” of the competition. The cooperation between lateral inhibitory and fast-
spiking interneurons would endow the striatal network with a number of advantages from a 
behavioural perspective. Thus, lateral inhibition would improve learning of a new action and 
associating the action outcome with its choice representation. On the other hand, feed-
forward inhibition would facilitate both selection of the most appropriate action and 
efficient shift between different actions, while also preventing competing actions from 
being active simultaneously.  
 
Addictive behaviours might then result from increased probability of “addictive action” 
ensembles being prioritised. In this framework, a deficit in inhibition from lateral inhibitory 
inputs (as expected with a loss of α2-GABAA receptor signals in the dendrites of MSNs), 
would conceivably alter the gain of the striatal output and bias the output of MSN 
ensembles. On the other hand, a deficit in α4-GABAA receptor-mediated tonic inhibition may 
impact feed-forward inhibitory inputs; however, the net effect of such deletion is difficult to 
predict as α4-GABAARs are expressed on both fast-spiking interneurons and the target MSNs 
(Maguire et al., 2014). Our comparative findings with mice selectively lacking the α4 signal 
in D1R- or D2R-MSNs or both neuronal populations, suggest that the α4-GABAA receptor-
mediated effect of feed-forward inhibition may be dependent on the MSN neuronal type, as 
D1R+ve MSN-mediated tonic inhibition acts to oppose an excessive DA tone, e.g. as 
associated with a psychostimulant (Maguire et al., 2014). Yet, D2R-MSN α4-mediated 
inhibition would appear to control motivation to obtain the reinforcing stimuli. It is 
tempting to speculate that distinct fast-spiking interneuron populations targeting either 
D1R- or D2R-MSNs may be activated by specific cortical inputs to elicit defined functional 
and behavioural outcomes. A similar dichotomy albeit with possibly different behavioural 
consequences may similarly apply to lateral inhibition where the role of D1R vs D2R-MSNs 
remains to be elucidated. Studies exploring such possibilities and how they may be affected 
by chronic drug intake are warranted in the near future.   
  
4. Integrating the human genetic and animal studies 
 
4.1. Altered subjective effects of drugs 
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The neurobiological mechanisms by which variations in non-coding regions of GABRA2 in 
humans translate into risk for addictions are not understood. Clearly, the rodent studies 
showing high density of α2-GABAA receptors in the NAcc (Dixon et al., 2010, Pirker et al., 
2000), a brain area associated with reward and motivation and implicated in drug abuse and 
addiction (Robbins and Everitt, 2007, Robinson and Berridge, 1993) provide a potential clue. 
As discussed above, deletion of α2-GABAA receptors in the mouse (α2 knockout mice) not 
only reduces GABAergic phasic inhibitory currents in accumbal medium spiny neurons 
(MSNs) by about 30% (Dixon et al., 2010), but also leads to altered function of systems 
thought to contribute to control over reward seeking (Dixon et al., 2010), and in particular 
to facilitation of reward-seeking by psychostimulants. Nevertheless, it is unknown whether 
human gene-variants conferring increased risk for addiction alter expression of α2-GABAA 
receptors in the brain, and through this mechanism affect incentive learning.  
 
NAcc activation during reward anticipation is enhanced in human adolescents carrying the 
GABRA2 risk G allele of rs279858 (Heitzeg et al., 2014), suggesting an effect on incentive 
processing consistent with reduced inhibition of accumbens MSNs, but direct evidence 
associating risk variants with changed α2 subunit expression is inconclusive (Haughey et al., 
2008). The rs299858 SNP creates a change in the triplet codon for amino acid residue 132, 
but does not change the protein sequence.  This and other intronic SNPs in the vicinity may 
tag a region that changes the stability / expression of the mRNA and thus alter expression of 
the GABRA2 gene. Some support for this interpretation comes from a recent report 
(Lieberman et al., 2015) that α2 mRNA is lower in neural cell cultures derived from 
rs279858*C allele (risk allele) carriers. If risk variants of GABRA2 reduce expression of α2 
subunits, might such risk variants have behavioural effects in humans that parallel the 
animal findings with genetic deletion of the subunit? 
 
Integrating data from animal and human experiments is often hindered by the use of 
different experimental measures in the two species (Stephens et al., 2010). However, using 
a human version of the mouse conditioned reinforcement test, we found similarities in the 
ability of the psychostimulant, methylphenidate, to facilitate instrumental responding for a 
conditioned reinforcer in mice with α2 subunit deletion, and humans carrying risk alleles for 
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cocaine addiction (Duka et al., 2015). In our experiment, we used possession of the G allele 
of SNP rs279871 in homozygosity as one of the identifiers of a genetic “risk” population. 
Although this SNP differs from those used in most studies of GABRA2, SNAP analysis of data 
from the 1000 Genomes Project (Johnson et al., 2008) shows rs279871 to be in 100% 
linkage disequilibrium with rs279858, the common risk SNP recognised across multiple 
studies of addicted populations (Covault et al., 2004, Fehr et al., 2006, Lappalainen et al., 
2005) and cocaine abuse (Enoch et al., 2010), as well as childhood conduct disorder (Dick et 
al., 2006b) and impulsivity during reward anticipation (Villafuerte et al., 2012). Thus 
variations in this genomic area may alone be driving our genotype differences.  It is thus of 
importance that SNP rs279858 is associated with a reduced α2 mRNA expression in 
neuronal cell cultures derived from the corresponding risk allele, consistent with (but not 
proving) a lowered  level of α2-GABAA receptors in rs279858 risk-allele carriers. 
 
Interestingly, in addition to loss of the ability of methylphenidate to facilitate conditioned 
reinforcement in the “risk” genotype, we also found marked changes in their subjective 
responses to the drug, specifically in ratings of drug-induced “restlessness”, “stimulated” 
and “arousal”. Other (Pierucci-Lagha et al., 2005, Roh et al., 2011), but not all (Arias et al., 
2014) previous studies found decreased subjective effects of another drug of abuse, alcohol, 
in measures of positive affect such as stimulation, vigour and happiness, in carriers of the C-
allele of rs279858. In keeping, carriers of the minor alleles for SNPs rs279858, rs279844, 
rs279845, rs279826, rs279828 and rs279836 had lower 'Negative' alcohol effect scores than 
individuals homozygous for the common allele at each SNP (Uhart et al., 2013).   
 
Furthermore, compared to heterozygous subjects, subjects homozygous for the high-risk 
allele at rs279871 displayed an increased response to alcohol-associated cues in medial PFC 
areas in an fMRI study; in contrast, the heterozygous subjects displayed an increased 
response in the ventral tegmental area (Kareken et al., 2010). Finally, in a family sample 
enriched for alcoholism, GABRA2 polymorphisms were found to be linked to increased 
activation in the insula with reward anticipation, suggesting that GABRA2 polymorphisms 
may be linked to not only alcohol reward and alcohol-related cues, but to a general 
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dysfunction of the reward system in alcohol-dependent subjects (Villafuerte et al., 2013, 
Villafuerte et al., 2012). 
 
4.2 Personality effects 
Such changes in reward-related behaviours may precede the development of alcohol 
dependence. An elevation in the risk for alcohol dependence associated with GABRA2 is not 
consistently apparent until the mid-20s, but then remains constant throughout adulthood 
(Dick et al., 2006b). Thus associations between GABRA2 risk haplotypes and sensitivity to 
reward or personality characteristics like impulsivity may interact with environmental 
factors leading to alcohol dependence at a later stage. One example of such a potential 
interaction is provided by a study of  the relationship between GABRA2 genotype and family 
status; while both GABRA2 and marital status contributed independently to the 
development of alcohol dependence, the high-risk GABRA2 variant is associated with a 
decreased likelihood of marrying, and an increased likelihood of divorce, which appears to 
be mediated by personality characteristics (Dick et al., 2006a).  
 
Taken together, these studies may suggest that the primary association of GABRA2 variants 
is with deficits in personality characteristics associated with behavioural control and with 
sensitivity to reward. Impairments in such control may reveal themselves in a variety of 
disorders which includes alcohol and drug abuse. Such impairments are sometimes referred 
to as “externalizing behaviours” and include aggression and rule breaking (e.g., defiance, 
theft, and vandalism) that are influenced by both genetic and environmental factors. 
Several studies have shown the association of adolescent externalizing behaviour with 
negative consequences in adulthood, but also how externalising behaviour in adolescents is 
influenced by parental monitoring. Recently, the Michigan group, examining GABRA2 
variants (rs279827, rs279826 and rs279858) in adolescents were able to show that 
adolescents with GABRA2 minor allele (GG, rs279827) are most susceptible to parental 
monitoring, both adverse and adaptive (Trucco et al., 2016a, Trucco et al., 2016b). Although 
the relationships between GABRA2 variants and parental monitoring influences seem to be 
primarily for delinquent behaviour rather than alcohol abuse, per se, the same variants are 
nevertheless associated with the development of problematic alcohol and drug use, if 
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delinquent behaviour is present in mid-adolescence (Trucco et al., 2014). Furthermore, 
persistence of delinquent behaviour from early adolescence to young adulthood (when 
problematic alcohol use develops) is associated with variants in the GABRA2 SNP (rs279858) 
(Dick et al., 2009). 
  
Such developmental trajectories may be the reason for apparently contradictory findings 
regarding GABRA2 polymorphisms and the presence of alcohol dependence. Clinically 
symptomatic Conduct Disorder, as well as less severe behaviours of delinquency, have been 
found to show patterns of behaviour persisting from early adolescence to young adulthood, 
but also declining when measured in a cohort of children followed from 11 years of age to 
22 years of age (Dick et al., 2009). Importantly, the individuals showing patterns of 
persistently high externalising behaviour were more likely to carry the GABRA2 variant 
(rs279858), that was found previously associated with increased risk for adult alcohol 
dependence (Edenberg et al., 2004). The association of GABRA2 with persistent 
externalising behaviour was influenced by parental monitoring; if parental monitoring was 
present the externalising behaviour was found to be less persistent.  
 
Regarding reward sensitivity as a factor influencing addictive behaviour, and returning to 
the animal literature, impaired control over reward-seeking may be a common feature, 
though directly comparable measures have been seldom carried out in both human and 
animal studies, to allow an integration of findings. Our own studies in GABRA2 “risk” 
individuals and α2  knockout mice (Duka et al., 2015) point to commonalities in 
psychostimulant effects on control over reward seeking, but how these relate to human 
conduct disorder deficits in risk individuals is at present a matter for surmise. Similarly,  
evidence that the ability of benzodiazepines to promote aggressive behaviour in mice is 
dependent on α2-containing receptors (Newman et al., 2015) is perhaps suggestive of 
involvement of such receptors in behavioural control.  However, there is much to do to 
integrate these kinds of observation into a systematic account. 
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4.2.1 GABAA receptor and impulsivity: an addiction-relevant relationship? 
 
Amongst higher order dysfunctions contributing to drug abuse, impulsivity appears to play a 
significant role. Variations in GABAA receptors play a significant role in impulsivity traits 
related to drug (and especially alcohol) misuse (Dick et al., 2010, Villafuerte et al., 2012, 
Villafuerte et al., 2013). Although impulsivity is a complex construct encompassing a number 
of behavioural traits, a significant body of work has linked the GABRA2 gene to a variety of 
clinical disorders characterised by a lack of impulse control, or general externalising  
behaviour (Dick et al., 2013). As many as 11 SNPs within the α2 gene have been associated 
with impulsivity and of these, four also associate with Lifetime Alcohol Problem Score 
(Villafuerte et al., 2013). A bootstrap analysis probing for a causal relationship for these 4 
SNPs suggests that about 25% of the association is mediated by their association with 
impulsivity, with the remaining 75% being accounted by other, yet to be identified, 
behavioural factors. A relationship between α2 and impulsivity and alcohol consumption 
has also been suggested in animals;  both the increased impulsivity and high alcohol 
consumption exhibited by adults rats exposed to a paradigm of early-life stress can be 
reversed by pharmacological manipulation of α2 GABAARs in selective neuronal locations 
(Gondre-Lewis et al., 2016)- see section 4.3).  
 
Moreover, GABRA2 SNPs associated with impulsivity associate with increased neuronal 
activation in both insula and NAcc (Villafuerte et al., 2012), thus providing some anatomical 
evidence for overlapping neuronal mechanisms and substrates between impulsivity and 
drug misuse mediated by variation in the α2 gene. How these genetic variants may 
influence GABAA receptor function at selective neuronal loci remains an open question 
though, as highlighted earlier, a recent study indicates a specific SNP, rs279858 to associate 
with reduced α2mRNA in an iPSC culture model (Lieberman et al, 2015). In this respect, the 
observation that in humans high levels of impulsivity in adolescents associate with a 
selective reduction in the GABA signal in the anterior cingulate cortex of adult subjects 
(Silveri et al., 2013) is of interest. Similarly, in animals, a decrease in GABAA receptor binding 
and GABA content in the anterior cingulate cortex and NAcc core respectively, have been 
reported for highly impulsive rats (Caprioli et al., 2014, Hayes et al., 2014). Future 
investigations should explore the impact of other identified SNPs on the receptor function 
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with the strongest impulsivity-associated SNPs, rs279827 close to a splicing site able to 
produce a truncated protein (Tang et al. 2005), emerging as a potential candidate. These 
studies will be instrumental in providing some of the starting points necessary to begin 
modelling the impact of GABAA receptor dysfunction at relevant neuronal networks. 
 
4.3 GABAA receptor gene-environment interactions 
 
As already noted, for certain addictions, variations in GABAA receptor subunit genes may 
interact with childhood trauma in predisposing to the development of an addictive 
phenotype (Enoch et al., 2010). For example, while experience of childhood trauma alone 
predicts the development of drug dependence (Enoch, 2011, Messina et al., 2008, Cadet, 
2016), this relationship is also markedly influenced by GABRA2 gene variants (Enoch et al., 
2010). A considerable animal literature implicates α2-GABAARs subunits in the anxiolytic 
actions of benzodiazepines and barbiturates (Low et al., 2000, Morris et al., 2006, Dixon et 
al., 2008, Dias et al., 2005, Smith et al., 2012), while genetic deletion of the α2 subunit 
increases the sensitivity of mice to conditioned anxiety (Dixon et al., 2008). In humans, a 
preliminary report suggests a strong correlation between GABRA2 genotype and amygdalar 
and insular activation in response to fearful faces (Stein et al., 2006). Thus, one distinct 
possibility is that variations in GABRA2 may increase risk for the development of addictions 
by increasing the emotional response to traumatic life events. In keeping with that 
hypothesis, (Nelson et al., 2009) reported that polymorphisms in GABRA2 interact with early 
childhood trauma in increasing risk for post-traumatic stress disorder (PTSD). Alternatively, 
early life exposure to traumatic events may alter GABAergic gene expression, resulting in 
altered receptor sensitivity, and sensitivity of gene expression to such events may depend 
upon genetic polymorphisms.  Exposure of rat pups to stress permanently diminishes 
GABAergic responses at hippocampal GABAA receptors, an effect that has been attributed to 
diminished transmission through α1GABAARs (Hsu et al., 2003). Very recently, we have 
found that exposure of mice to early life stress during postnatal days p2 to p9 leads to a 
specific reduction in adulthood of α2 but not α1 subunit expression in ventral striatum, 
leading to impaired GABAergic inhibition of accumbal medium spiny neurons, and altered 
responses to cocaine that resemble those in α2 knockout mice (Lambert, 2013) .  
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In keeping, maternal separation in rats has been shown to engender in adult animals an 
increase in indices of both impulsive and alcohol binge-like drinking behaviours, which 
associated with a selective increase in the protein levels of the GABAAR α2 subunit in the 
mPFC and the amygdala. Remarkably, micro-infusion of 3PBC, a ligand that selectively 
inhibits α2-GABAA receptors in either locus, reversed the maternal separation-evoked 
increase in both behavioural measures, an effect also mimicked by local administration into 
the amygdala of antialarmin, a CRF antagonist (Gondre-Lewis et al., 2016). Collectively, 
these findings suggest that a coordinated regulation of expression levels of α2-GABAA 
receptors at selective but overlapping neuronal loci of the stress and motivational circuits 
may mediate the effects of early-life stress on the increased risk for excessive drinking.  
 
Additional GABAA receptor isoforms may also be sensitive to environmental influences. 
Thus, consistent with a specific pattern of altered expression of distinct GABAA receptor 
subtype following exposure to early-life stressor, a selective decrease in α3 but not α2 
subunit expression in the amygdala and an associated increase in anxious-like behaviour has 
been reported for a peri-pubertal stress paradigm in rats (Tzanoulinou et al., 2014).  
Intriguingly, a persistent down regulation of Gabrd in the VTA of rats exposed to chronic 
physical or emotional stress has been also reported and is accompanied by behavioural 
abnormalities indicative of a depressive-like behaviour (Warren et al., 2013). A decreased 
expression of α3-containing and/or δ receptor isoforms, which mediate tonic inhibition in 
the amygdala (Marowsky et al., 2012) and other neuronal populations within motivational 
pathways (Fig 5), may also contribute to addictive behaviour.  
 
4.3.1 Neurosteroids: a role in neurocircuits involved in addiction? 
 
In the context of interactions between early-life stress and GABAA receptor function, it is 
worth noting that the function of such receptors can be endogenously facilitated 
allosterically by a group of brain-derived neurosteroids (Belelli and Lambert, 2005, Gunn et 
al., 2015). Therefore, variations in the neuronal levels of neurosteroids can impact on 
GABAA receptor function across the CNS. Our recent electrophysiological and 
immunohistochemical analysis in the NAcc has revealed that both synaptic and 
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extrasynaptic GABAA receptors in MSNs are sensitive to physiological concentrations of 
neurosteroids while immunoreactivity for one neurosteroid, allopregnanolone, is evident in 
MSNs (DARPP-32 positive), but also DARPP-32 negative cells, presumably interneurons or 
glia cells (Mitchell, Belelli and Lambert, unpublished). Collectively these findings are 
consistent with previous reports suggesting a role for endogenous neurosteroid in the 
modulation of NAcc function via GABAA receptors (Frau et al., 2013).   
 
Of specific relevance in the contest of substance abuse, it has been suggested that alcohol 
may mediate some of its actions by modulating the synthesis of these GABAA receptor-
active neurosteroids (Sanna et al., 2004, Kumar et al., 2009, Morrow et al., 2006). In 
keeping, a number of publications have found effects of allopregnanolone on ethanol 
operant self-administration by rats (Janak et al., 1998, Janak and Michael Gill, 2003), while 
the administration of the synthetic analogue, ganaxalone, reduced limited access ethanol 
consumption in mice, when given either systemically (Ramaker et al., 2012), or into NAcc 
(Ramaker et al., 2015). Importantly, knocking out the gene encoding the 5a-reductase type I 
gene, essential in the synthesis of allopregnanolone, increased ethanol consumption in 
female mice (Ford et al., 2015).  While the relationship between alcohol intake and 
neurosteroid signalling is complex, the observation that tolerance to the alcohol-induced 
increase in neurosteroid levels developed in alcohol-dependent animals (Khisti et al., 2005) 
suggests this adaptation may contribute to the excessive alcohol consumption in such 
animals (reviewed in Morrow et al. 2006). Detailed investigations into neurosteroid 
production and its regulation in relevant neuronal loci in rodent lines selectively bred for 
alcohol consumption are still limited. However, neurosteroid content, sensitivity and 
synthetic enzyme expression levels (e.g. 5α-reductase) are differentially altered in alcohol-
withdrawal seizure-prone and resistant mouse lines (Tanchuck et al., 2009), thus indirectly 
supporting a dynamic relationship between alcohol, neurosteroids and GABAA receptor 
function. Future targeted studies exploring the role of a range of neurosteroids are 
necessary to clarify a GABAA receptor-mediated role of neurosteroids in alcohol actions 
(Porcu and Morrow, 2014) . In that context it is of interest that that GABRA2 alleles 
influence the ability of finasteride (5 alpha-reductase inhibitor that decreases levels of 
GABAA receptor active neurosteroids) to decrease the subjective effects of alcohol, 
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suggesting that certain effects of neurosteroids are mediated by α2-GABAARs (Pierucci-
Lagha et al., 2005). 
 
4.4 EEG related changes; a potential biomarker for GABRA2 variants? 
Electrical activity of the brain measured by EEG and, in particular, β power (brain waves of 
15 to 30 Hz) has been proposed as a key endophenotype for alcohol and cocaine 
dependence (Costa and Bauer, 1997). Further studies have confirmed the increase of beta 
power in alcoholics (Rangaswamy et al., 2002) but also in individuals with family history of 
alcoholism (Rangaswamy et al., 2004, Bauer and Hesselbrock, 1993). Variations in GABRA2 
have been found to be strongly associated with the β frequency which represents 15–20% 
of the resting awake EEG in the majority of healthy adults (Edenberg et al., 2004). 
Furthermore because variations in the GABRA2 gene affect the level of neural excitability, it 
has been proposed that such increase in neuronal excitability would predispose to alcohol 
abuse and dependence. 
 
In a cohort of 44 alcohol dependent patients who had been abstinent from alcohol for a 
minimum of 24 months a significant association between four GABRA2 SNPs (rs548583, 
rs279871, rs279863, rs279841) and increased EEG β power was found (Lydall et al., 2011) 
Increased β power has been reported in the EEGs of the offspring of alcohol dependent 
parents, and in individuals with a family history of alcohol dependence. Recently an 
association between the GABRA2 gene and beta power was confirmed in a community 
sample of 4,026 twin adolescents, and parents genotyped for 527,829 SNPs (Malone et al., 
2014). 
 
How could an altered GABAergic signal mediated by α2-GABAAR lead to an increase β power 
EEG? A comparison with our current understanding of the increased power of β oscillations 
associated with Parkinsonism may be instructive in this respect (Goldberg et al., 2002, Costa 
et al., 2006). Recent studies in human and in animal models of Parkinson’s disease, 
combined with computer modelling have suggested that a decrease in lateral inhibition 
plays a crucial role in driving the increased β power. In these studies, deficits in DA, typically 
associated with Parkinson’s disease, primarily cause a reduction in lateral inhibition that 
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appears to provide a crucial drive for the increased power of the β oscillation (Damodaran 
et al., 2014, Damodaran et al., 2015). Thus, it is tempting to speculate that if the effect of 
the α2 SNPs does indeed translate to a reduced GABAAR function, as suggested by recent 
reports (Lieberman et al., 2015), this could in turn similarly weaken lateral inhibition 
through the reduced α2-GABAA receptor signal. Such an effect may be particularly evident 
at synaptic locations along MSN dendrites where GABA would normally facilitate incoming 
glutamatergic signals to increase MSN firing (see section 3.2.3). Inhibition may also be 
decreased by the loss of the α2-GABAAR signal on the soma of MSNs (which make up an 
estimated 30% of the synaptic charge) and combined with a reduction in lateral inhibition, 
these alterations may be sufficient to entrain more MSNs into the β frequency range under 
the strong influence of fast-spiking interneurons firing, as previously demonstrated for both 
hippocampal and cortical assemblies (Buzsaki and Chrobak, 1995, Gray, 1994). It is also 
possible that these changes may be accompanied by additional alterations in the MSN 
intrinsic properties e.g. K+ conductances, which are known to be sensitive to changes in 
GABAA receptor function (Czubayko and Plenz, 2002, Plenz, 2003) and/or fast-spiking 
interneurons synchronized firing (Damodaran et al., 2014, Damodaran et al., 2015). 
Furthermore, a reduction in the α2-GABAA receptor-mediated conductance in 
interconnected areas e.g. cortex may additionally contribute to the increased power of the 
β oscillation.  
  
5. Conclusions 
Investigations of the past decade into the role of GABAA receptors in drug addiction and 
dependence have begun to uncover the complexity of the modalities whereby different 
GABAA receptor isoforms orchestrate the integration of dopaminergic and glutamatergic 
signals within the reward pathway. Although human genetic association studies provide 
provocative evidence that certain genetic variants are associated with various addictions, 
the biological link between the genetic variations and addictive behaviour remains largely 
unexplained. And while animal studies have identified a number of potential behavioural 
changes following manipulation of specific subtypes of GABAA receptor, integrating those 
findings into a broader account of addictive behaviour remains a task to be undertaken.  
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
For the moment, we can point to α2-GABAA receptors as playing an important (albeit 
unknown) role in striatal inhibition, and to interactions between psychostimulant drugs and 
reward-conditioned behaviour, while variants in the genes encoding those same receptors 
appear to be associated in a complex fashion with behavioural traits predisposing (inter alia) 
to addictive behaviour. A clear answer to the question of whether human GABRA2 gene 
variants have consequences for regulation of α2−GABAA receptor expression in people is 
urgently needed, as are tools for understanding the spatial and temporal organisation of the 
different receptor isoforms within specific neuronal populations and cellular domains, and 
interrogation of their respective physiological roles within the relevant neuronal networks. 
Nevertheless, the presently available data are consistent with a role of α2-GABAA receptors 
in protecting against factors predisposing to addictive behaviour.  
 
It is a curiosity that while no human genetic association data provide a link between 
GABRA4 polymorphisms and addictions, within animal studies, discrete manipulations of 
α4-GABAA receptors have suggested they play an important role in striatal physiology, and 
that their manipulation has important consequences for motivation to obtain and consume 
alcohol, but also suggest they play a role in aspects of psychostimulant reward. Similarly, 
GABRA1 polymorphisms have not been identified as associating with human addictions, 
while animal data suggest that deletion of this subunit decreases alcohol (and sucrose) 
intake. 
 
Hitherto, the ubiquitous role of GABAergic inhibition across the entire brain, and the non-
selective actions of drugs influencing GABAergic transmission has meant that 
pharmaceutical manipulation of GABAergic systems has been non-specific, both with regard 
to the neuronal system addressed, and the behavioural consequences of drug treatment. 
The advances in understanding the particular roles of GABAA receptor subtype in different 
aspects of addictive behaviour outlined in this review, now begin to hold promise that it 
might be worthwhile targeting specific receptor subtypes to influence addictive behaviour. 
While we are still some way from providing a rational therapeutic approach, it would seem 
worthwhile to investigate whether selective facilitation of α2-GABAA receptors might be 
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useful for controlling addictive behaviours. While such drugs are not yet available clinically, 
prototypes have been developed (Atack, 2011). 
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Figure Legends 
 
Figure 1. The relative expression of GABAA receptor isoforms in rodent brain and a 
simplified model of the receptor. GABAA receptors are made up of five protein subunits, 
that are arranged to form a central ion channel permeable to chloride and bicarbonate 
anions. The majority of proteins making up the complex come from 3 related subunit 
families, named α (1-6), β (1-3) and γ (1-3). Most commonly receptors are made of two 
members of the α family, two β, and one γ  subunit although in some cases the γ subunit 
may be substituted by a δ subunit. The GABA (G) binding sites are formed by the N-terminal 
large extracellular domains between the α and β subunit interface and the benzodiazepine 
(Bz) site is similarly formed by the N-terminal extracellular domains between the α and γ 
subunit interface. A putative binding site for the neurosteroids (N) is shown within the 
transmembrane region of the α subunit.  
 
Figure 2. Chromosomal locations of major GABAA receptor gene clusters.  The genes for 
individual subunits are present in clusters conserved across mammalian genomes. The 
figure shows the four main gene clusters and their relative locations on human and mouse 
chromosomes (shown on human and mouse chromosomes in red). The red arrow 
designates prientation along the chromosome. These clusters are expanded and the 
arrangement of the genes within them encoding the individual subunits displayed. α 
subunit genes are shown in red, β subunit genes are blue, γ subunit genes are green. Other 
GABAA receptor subunit families are shown in yellow. The subunits are encoded by the 
following genes: α1, GABRA1; α2, GABRA2; α3, GABRA3; α4 GABRA4; α5, GABRA5;  β1, 
GABRB1; β2, GABRB2; β3, GABRB3; γ1, GABRG1; γ2, GABRG2, γ3, GABRAG3; ε, GABRE; 
θ, GABRQ.  Black arrows indicate the direction of transcription for the individual genes.  
 
Figure 3. Synaptic and extra-synaptic GABAAR isoforms in the reward circuitry.  
A sagittal section of a rodent brain illustrating the expression profile of both synaptic and 
extra-synaptic GABAA receptor isoforms throughout the reward circuitry. Depicted within 
this circuit are the principal excitatory (green), inhibitory (red) and dopaminergic (blue) 
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projections. The reported expression of GABAAR subtypes is derived from both 
immunohistochemical and electrophysiological studies (see text).  
Note that GABAAR isoforms responsible for mediating phasic and tonic inhibition are 
expressed in a neuron-specific manner throughout the mesolimbic neurocircuitry. For 
example, in the NAcc, in addition to the α4βδ subtype, αxβγ2 are expressed 
extrasynaptically on MSNs. Of this pool, a proportion has been suggested to incorporate the 
α5 subunit (Lingford-Hughes et al., 2012, Mendez et al., 2013). An extrasynaptic localization 
of α5-containing GABAARs has also been reported for MSNs of the dorsal striatum (Ade et 
al., 2008), where, however, their developmental expression in rodents has been debated  
(Janssen et al., 2009, Santhakumar et al., 2010). See also Fig 5 for detail on GABAAR isoforms 
expressed in the NAcc.  For simplicity, GABAAR isoforms expressed in various regions of the 
amygdala are not displayed but a discussion can be found in (Marowsky et al., 2012, 
Herman et al., 2013). Similarly, note that in the VTA α1βγ2 and α3βγ2 subtypes are 
selectively expressed in GABAergic interneurons and dopaminergic neurons respectively 
(Tan et al., 2010, Okada et al., 2004).  A population of extrasynaptic α4βδ receptors has also 
been described for VTA GABAergic interneurons (Vashchinkina et al., 2012, Xiao et al., 
2007).  
 
 
Figure 4. Postulated influence of α2-GABAA receptor activation on control of addiction-
related, broad behavioural constructs 
 
A) Shows normal conditions of non-susceptible brain. α2-GABAAR activation allows 
control over delinquent behaviour, and potentiates control over motivation to take 
the drug. The negative sign (-) denotes the general inhibitory effects of GABA in the 
brain 
B) Shows the susceptible brain because of GABRA2 risk variants present which lead to a 
hypothesised reduction of GABA function. A tendency towards delinquent behaviour 
is facilitated by weakness in parental monitoring, leading to reduction of control over 
motivation to take drugs. These behavioural aspects weaken the control over 
motivation to take the drug  
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(Note: We speculatively ascribe a role to GABAA receptors in modulating the output 
between motivation and drug-taking, on the basis of the association of GABRA2 variants 
with subjective effects of drugs including psychostimulants and alcohol).  
 
 
 
 Figure 5.  Synaptic and extra-synaptic GABAAR isoforms expressed in the MSNs and 
interneurons of the NAcc and the effect of early-life stress and identified SNPs upon their 
expression and the EEG β power. 
 
NAcc core neurocircuitry and the GABAA receptor isoforms expressed in the MSNs and Fast-
Spiking Interneurons (FSIs). MSNs receive a powerful inhibitory input on their soma from 
parvalbumin-containing FSIs, giving rise to feed-forward inhibition (FFI). Additionally, fast-
spiking interneurons, which are coupled via gap junctions, send a much weaker input to 
MSN dendrites. MSNs can inhibit each other via lateral inhibition (LI) and receive powerful 
glutamatergic inputs from a number of limbic and forebrain regions and dopaminergic 
inputs from the VTA, largely on their dendritic tree (see Fig 3 for details). Burst DA firing is 
likely to target synaptic receptors whereas tonic DA firing may affect largely extrasynaptic 
receptors. DA actions are mediated by D1R and D2R on direct and indirect pathway MSNs 
respectively although this view has been recently challenges for the NAcc (Kupchik et al., 
2015). Changes in lateral inhibition, due to decreased α2 GABAAR in rodents (as a result of 
early life stress, (Lambert, 2013)) or humans (dependent on specific GABRA2 variants e.g. 
SNP rs279858 (Lieberman et al., 2015)) might be the basis for the increased beta power 
measured in EEGs (Costa and Bauer, 1997, Rangaswamy et al., 2002, Edenberg et al., 2004, 
Lydall et al., 2011).   
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Figure 2 
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Figure 3 
 
 
 
 
  
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Figure 4
 
A Non s
 
B Susce
 
 
GABR
usceptible
ptible brai
A 2 genetic
 brain 
n 
 variants support conditions of risk to drug abuse 
 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Figure 5
 
 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved.
